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Abstract 
 
 
The transcription factor Sox2 has a key role not only in maintaining stem state 
but also in specification of neural fate of embryonic cells. Multiple regulatory 
elements have been identified in the Sox2 locus (Uchikawa et al, 2003). In the 
developing embryo, these regulatory elements are activated differentially in 
time and space. We studied the activity of 25 defined regulatory elements of 
the Sox2 promoter in three different lines of chick ES cells. By transfection of 
plasmids encoding Enhanced Green Fluorescent Protein (EGFP) and the 
minimal promoter thymidine kinase (tk) coupled with individual Sox2 regulatory 
elements we find that the Sox2 enhancer N2 has the highest activity in 
proliferating chick cell lines compared with other enhancer regions. Under 
conditions that induce ES cells to differentiate into neurons the activity of the 
N2 enhancer increased along with an increase in levels of expression of Sox2 
mRNA. Further analysis of the N2 enhancer sequence identified two sub-
regions with 176 and 73 base pairs (bp) which are highly conserved between 
chick, mouse and man. Functional studies performed with the tk-EGFP 
reporter plasmids under the control of five regulatory sequences containing the 
mouse N2 enhancer in its full length, its two sub-regions (176 and 73 bp) or 
sequences composed of the full length of the mouse N2 from which each of 
the two sub-regions 176 bp and 73 bp has been deleted confirmed that the 
two sub-regions of the N2 enhancer account for its activity in both proliferating 
cES cells as well as their induced neural differentiation state. These findings 
suggest that N2 core regulatory regions encode conserved instructions 
required to direct expression of Sox2 both in embryonic stem cells induced to 
neural differentiation and in the neural plate of the embryo itself. 
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Chapter 1. Introduction 
1.1. Stem Cells 
 
Stem cells are defined as cells with the ability to self-renew, perhaps 
indefinitely, without becoming malignant or aneuploid (Atala, 
2005;Constantinescu, 2003; Gardner and Brook, 1997; Loeffler and Roeder, 
2002; Smith, 2001). In some instances, but not necessarily, stem cells may be 
pluripotent (ie. able to give rise to many cell types) or even totipotent (any cell 
type including the germ line). Endogenous stem cells with demonstrated self-
renewing capacity have been found in many adult tissues, especially those 
that are subjected to abrasion or other cell loss and therefore require the cell 
population to be replenished throughout life. Well-studied examples include 
the basal layer of the skin (Watt, 1988; Watt, 1998), intestinal crypts (Potten, 
1991; Potten and Loeffler, 1990), bone marrow and other haematopoietic 
precursor sites (Antica et al., 1994; Graham and Wright, 1997; Loutit, 1968) 
and the olfactory epithelium (Calof et al., 1998; Murray and Calof, 1999).  
 
The term “stem cell” was first coined as long ago as 1908 by Alexander 
Maximov, who first proposed the concept of self-renewing progenitor cells to 
account for the generation of blood cells throughout life. However it was not 
until the 1960s that the concept became more firmly established through 
further studies of self-renewing cell populations both in the haematopoietic 
system, notably by Till and McCulloch (McCulloch and Till, 1964; Till and 
McCulloch, 1963)  and in the skin and hair follicles, by C S Potten and others 
(Potten et al., 1979; Potten, 2004; Potten and Morris, 1988) 
 
A further turning point came from studies on teratocarcinoma cells, which 
could be cultured indefinitely and cells retained their undifferentiated state. 
These cells were called embryonic carcinoma cells (ECCs) (Martin and Evans, 
1975). This paved the way to the production of the first embryonic stem (ES) 
cells, derived from the inner cell mass of mouse blastocysts before 
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implantation (Evans and Kaufman, 1981; Martin, 1981). Eventually, ES cells 
were generated from human embryos (Shamblott et al., 1998; Thomson et al., 
1998). Just before the turn of the century, ES-cell like cells were successfully 
generated from several other animal species such as the pig (Wheeler, 1994), 
rhesus monkey (Thomson et al., 1995) and chicken (Pain et al., 1996). In 
anamniotes, the establishment of cell lines with some ES-cell like 
characteristics has been described for zebrafish (Sun et al., 1995) but a 
demonstration that these are true ES cells or even pluripotent has yet to be 
provided. 
 
Four essential features have been proposed to define Embryonic Stem (ES) 
cells. First, the key characteristic of all stem cells: they have the capacity, to 
self-renew, perhaps indefinitely, without change of their genotype or their 
phenotype. Second, ES cells are pluripotent (or even totipotent): they have the 
potential to differentiate into any somatic cell lineage, including derivatives of 
any of the three embryonic germ layers (ectoderm, mesoderm and endoderm). 
Third, in addition to their somatic pluripotency, true ES cells can contribute to 
germ cells: when transplanted into blastocyst-stage embryos they are able to 
contribute to every tissue type including the germ-line and can therefore give 
rise to a new individual. This property has been exploited in the last few 
decades as an effective way to construct transgenic mice, since gene 
manipulations can be done using homologous recombination in ES cells which 
can then be used to generate germ line chimaeras and generate transgenic 
animals (Gordon et al., 1980; Gordon and Ruddle, 1981; Ruddle, 1981; Shows 
and Sakaguchi, 1980). Finally, ES cells are able to form teratocarcinomas 
(undifferentiated malignant tumours composed of tissue resembling normal 
derivatives of all three germ layers - their name is derived from the Greek word 
“terato”, meaning monster) when they are introduced into adult tissue 
(Andrews et al., 2001; Matsui et al., 1992).  
 
These characteristics distinguish ES cells from other cells with the capacity to 
self-renew and differentiate into multiple cell lineages with role in tissue repair 
and regeneration such as the haematopoietic system (Barnes and Loutit, 
1967; Loh et al., 2009) and skin (Watt, 1998).  
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ES cells have attracted a great deal of interest by the public as well as in 
biomedical research domains. On one hand, their ability to self-renew and 
differentiate into many different cell types has raised hope for using them as 
tools for tissue regeneration and repair. On the other hand, their ability to 
integrate into host blastocysts and form chimaeras provides a powerful tool for 
studying developmental processes and gene function (Beddington and 
Robertson, 1989; Shows and Sakaguchi, 1980). 
 
Over the last three decades, research on the biological properties of ES cells 
themselves has uncovered many mechanisms governing cells self-renewal, 
commitment and differentiation. Factors maintaining pluripotency have been 
identified, including the cytokine leukaemia inhibitory factor (LIF) (Niwa et al., 
1998; Smith and Hooper, 1987) and intracellular proteins such as p21 and p53 
(cell cycle regulators) (Aladjem et al., 1998; Savatier et al., 1996).  More 
recently, it was discovered that transfection of just four transcription factors 
(Sox2, Klf4, Myc and Oct3/4) is sufficient to cause somatic, differentiated cells 
to re-enter the cell cycle and to become pluripotent. Cells so treated are 
known as induced Pluripotent Stem cells  (iPS cells) (Takahashi and 
Yamanaka, 2006; Yamanaka, 2008) (see also below, iPS Cells). 
 
These discoveries, along with renewed intensity of investigation into the 
molecular mechanisms governing cell and tissue replacement, ushered the 
birth of a whole new area, regenerative medicine. Examples of possible future 
applications include replacement of damaged cardiomyocytes following 
myocardial infarction (Nelson et al., 2009; Zhang et al., 2005), of dopaminergic 
neurons in Parkinson’s disease (Chiba et al., 2008), of nephrons in end stage 
renal failure (Aboushwareb and Atala, 2008; Gupta et al., 2006; Koh and 
Atala, 2004; Perin et al., 2010)or of beta-islands cells in diabetes (Chang et 
al., 2007; Maehr et al., 2009; Zhao et al., 2006), to name just a few. 
 
Understanding the processes behind cell fate decisions and lineage 
specification will be essential to direct differentiation of pluripotent cells into the 
required cell types to replace cells lost in disease or injury (Atala, 2009a; 
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Atala, 2009b; Smith, 2001). Although still limited, this approach has already 
started to benefit individual patients who have received stem cells or 
engineered tissues to reconstruct malformed or damaged structures 
(Macchiarini et al., 2008). 
 
1.2. The chick embryo model and avian ES cells 
 
During embryo development, all adult tissues arise from a single cell: the 
fertilized egg. Soon after fertilization this mother cell undergoes multiple cell 
divisions to generate daughter cells which progressively become specified to 
different fates. In amniotes, embryonic cells remain multipotent (or even 
totipotent) for several divisions before starting to become committed to sub-
sets of fates. Understanding how the embryo allocates cell fates is crucial if we 
are to be able to control the differentiation of cultured ES cells to generate the 
desired cell types for clinical and other applications. Of particular interest are 
the mechanisms responsible for cells becoming specified to neural fates. The 
chick embryo has for a long time been a powerful model to study 
developmental processes including neural induction – how cells choose 
between neural and other fates (Stern, 2004b; Stern, 2005a; Stern, 2006). The 
early neural plate of vertebrates, from where the entire CNS arises, is initially 
defined by its expression of transcription factors of the SoxB1 class, including 
Sox2 (Collignon et al., 1996; Rex et al., 1994; Rex et al., 1997b; Uwanogho et 
al., 1995), which is one of the transcription factors identified as key regulators 
of pluripotency (see above). This project takes advantage of chick embryonic 
stem (cES) cells to investigate the molecular mechanisms that regulate Sox2 
expression in pluripotent stem cells and in early neural cells.  
 
The following sections briefly introduce the chick model, its early development 
and cES cells that can be derived from early chick embryos. Then, it reviews 
the mechanisms regulating multipotency and neural induction focusing on 
SoxB1 family of transcription factors. 
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1.2.1. Early development of the chick embryo  
 
After fertilization, which is polyspermic, the chicken embryo develops in utero 
for about 20 hours before the egg is laid. Cleavage is meroblastic, or unequal, 
causing cells at the periphery of a cleaving disk to be open to the surrounding 
egg yolk (reviewed in (Stern, 2004a)). By the time of laying (stage X of 
fourteen pre-primitive streak developmental stages [Roman numerals I-XIV] 
defined by (Eyal-Giladi and Kochav, 1976) the embryo contains 20,000-50,000 
cells (Spratt and Haas, 1960). They are arranged as a flat disk of about 3mm 
diameter, covered by an acellular vitelline membrane and separated from the 
yolk by the subgerminal cavity see (Stern, 2004a). 
 
Two areas can be distinguished in the embryo at this stage: a more 
translucent inner region, the area pellucida and an opaque, thicker outer ring, 
the area opaca. All embryonic tissues arise from the area pellucida which 
could therefore be considered to be equivalent to the mammalian inner cell 
mass. The outer area opaca gives rise only to extraembryonic tissues and is 
more similar to the trophectoderm of rodent embryos.  
 
At stage X, the area pellucida is composed of a continuous layers of cells, the 
epiblast, an epithelial sheet that extends over both area pellucida and area 
opaca. The epiblast is underlain ventrally by loose “islands” of about 5-20 
large, yolky cells: the hypoblast. Only the epiblast contributes cells to the three 
germ layers of the embryo (Stern, 2004a). 
 
Soon after laying, the islands of hypoblast cells spread out to form a layer, 
expanding in a posterior to anterior direction to form the hypoblast layer 
proper. This layer does not contribute cells to the embryo but has several 
important functions in development including: directing cell movements of the 
overlying epiblast (Foley et al., 2000; Voiculescu et al., 2007; Waddington, 
1932), preventing premature primitive streak formation while the axis relocates 
to the midline (Bertocchini and Stern, 2002), induction of the earliest steps of 
neural induction mainly through its secretion of FGF (Albazerchi and Stern, 
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2007; Foley et al., 2000; Streit et al., 2000) and as a vehicle to transport 
primordial germ cells to the germinal crescent (Ginsburg et al., 1989; Stern, 
2004a). Stages X-XIII mark different stages in the expansion of the hypoblast 
layer, with stage XIII corresponding to the formation of a layer that fully covers 
the area pellucida (Eyal-Giladi and Kochav, 1976). 
 
Immediately thereafter, a new cell type arises from deep cells at the posterior 
margin of the area opaca/pellucida border: the endoblast (Bertocchini and 
Stern, 2002; Stern, 1990) at stage XIV. This tissue displaces the hypoblast 
anteriorly. It has been shown that the hypoblast prevents premature primitive 
streak formation because it produces Cerberus, an inhibitor of Nodal, and 
removal of the hypoblast (and thereby of this inhibitor) by the expanding 
endoblast cells at the posterior end of the embryo releases Nodal signalling 
which initiates primitive streak formation from the overlying epiblast 
(Bertocchini and Stern, 2002).  
 
From the time of appearance of the primitive streak a different staging system 
is used, described by Hamburger and Hamilton (1951) (HH), denoted in Arabic 
numerals. Stage 2 marks the appearance of a short, triangular primitive streak 
(the original HH Stage 1 has been replaced by the fourteen stages of (Eyal-
Giladi and Kochav, 1976) [Roman numerals]).  
 
Stages 2-4 of (Hamburger and Hamilton, 1951) correspond to the period 
known as gastrulation, during which the three definitive germ layers are laid 
down. The primitive streak is a midline thickening of the epiblast through which 
cells ingress and colonise the deeper parts of the embryo. A middle layer 
arises, and some of its cells migrate deeper still to colonise the 
hypoblast/endoblast layer, which eventually becomes displaced to the 
periphery of the embryo. The new deep layer is the definitive endoderm which 
will give rise to the lining of the gut and contribute to associated organs 
(Bellairs, 1953a; Bellairs, 1953b; Kimura et al., 2006; Sanders et al., 1978; 
Stern, 1990; Stern, 2004a; Stern and Canning, 1990; Stern and Ireland, 1981). 
 18 
The cells remaining in the middle layer will become the mesoderm, subdivided 
into axial (prechordal and notochord regions), paraxial (including prospective 
somites), intermediate (Wolffian duct and mesonephric kidney), cardiac and 
lateral plate mesoderm. The latter will eventually give rise to the vasculature, 
blood islands, coelomic lining and limb mesenchyme and contribute cells to 
many internal organs; see (Bellairs and Osmond, 2005).  
 
At HH Stage 4 the primitive streak has reached its full length and ingression 
stops through its most anterior part (Gallera, 1971;Sheng et al., 2003). The 
anterior tip of the primitive streak at this stage appears as a bulbous 
thickening, known as Hensen’s node (Hensen, 1876). This is an important 
structure because it has the unique ability to induce a complete nervous 
system from epiblast cells when transplanted to an ectopic site; see (Stern, 
2004a;Waddington, 1932). Immediately thereafter (HH Stage 5) the notochord 
starts to emerge as a rod extending anteriorly from the deep part of Hensen’s 
node. Simultaneously the paraxial mesoderm emerges from the node and 
immediately posterior regions of the streak, and colonises the sides of the 
notochord in the middle layer (Psychoyos and Stern, 1996; Selleck and Stern, 
1991). Both notochord and paraxial mesoderm subsequently elongate 
caudally as the primitive streak regresses, eventually to form the tail bud 
(Bellairs and Osmond, 2005) 
 
Current evidence suggests that commitment of cells to a neural fate occurs 
between stages 4 and 5. The epiblast above and on either side of the portion 
of the notochord (“head process”) that arose between these stages starts to 
become a more columnar, thickened epithelium, corresponding to the future 
cephalic neural plate. At stage 5, the position of the node corresponds to the 
level of the future otic vesicle (rhombomeres 5-6 of the hindbrain). The 
nervous system caudal to this level arises from two very small, paranodal 
regions of the Stage 5 epiblast (Diez Del Corral et al., 2003; Storey et al., 
1995; Uchikawa et al., 2003). 
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From laying until immediately before the appearance of the primitive streak, 
the blastoderm has remarkable regulative ability. If a blastodisc is cut into 
fragments (halves, quarters or even eight pie-shaped pieces), each piece can 
generate a complete embryonic axis (Lutz, 1949; Spratt and Haas, 1960). We 
do not yet know to what extent individual cells of the embryo at this stage are 
multipotent or whether the embryo is a mosaic of cells of different prospective 
fates. However these findings reveal that the normal embryo contains 
mechanisms to generate pattern from a population of cells with multiple 
potentials, and also that during normal development embryos must possess 
mechanisms that suppress the formation of supernumerary axes (twins) other 
than at the posterior part of the area pellucida; see (Bertocchini et al., 2004; 
Spratt and Haas, 1960). This remarkable level of regulation is unique to 
amniote embryos. Because polarity of anamniote embryos is determined by 
localisation of maternal components during early cleavage stages and 
because of the absence of zygotic gene expression during the first 11 or so 
cell divisions, amphibian embryos lose their ability to regulate if cut after the 
third or so cell division (Stern, 2004a). 
1.2.2. Chick embryonic stem cells  
 
Chimera formation and germ line transmission was achieved by injection of 
chick stage X blastodermal cells into recipient embryos (Marzullo, 1970; 
Petitte et al., 1990).These findings prepared the way for the generation of cell 
lines from chick blastoderm cells that share many of the characteristics of 
mammalian ES or Epiblast Stem cells (Pain et al., 1996; Petitte et al., 2004; 
Van de Lavoir and Mather-Love, 2006). These cell lines can be maintained 
indefinitely. However although cES cell lines have the ability to contribute to 
most if not all somatic cell lineages, they do not appear to be able to contribute 
to the germ line either in vitro or in chimaeras (Lavial and Pain, 2010). 
Therefore cES cells are more akin to mouse Epiblast Stem Cells (Epi Stem 
cells) than to true mammalian Embryonic Stem cells (ES cells). 
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1.2.2.1. Isolation and culture conditions 
 
Chick ES cells are derived form stage X blastodermal cells by culturing them 
on feeder layers of irradiated embryonic fibroblasts or other cell types 
(Carsience et al., 1993; Pain et al., 1996; Petitte et al., 1990). Their 
proliferation is dependent on the presence of several cytokines including LIF, 
stem cell, factor (SCF), insulin-like growth factor 1 (IGF1), interleukin 11 (IL-
11) and basic fibroblast growth factor (bFGF) (Pain et al., 1996). Later work 
undertaken to simplify this medium showed that maintenance of proliferation 
can be achieved with avian LIF and serum (Horiuchi et al., 2004). 
 
1.2.2.2. In vitro differentiation potential 
 
Chicken ES cells have been reported to differentiate into cells of displaying 
markers of all three germ layers (Pain et al., 1996). Differentiation protocols for 
chick ES cells are based on those developed in their mouse and human 
counterparts. Removing components of medium that maintain proliferation of 
cES cells such as LIF slows proliferation and causes progressive loss of stem 
cell/pluripotency markers such as SSEA1, PouV and Nanog (Lavial et al., 
2007;Pain et al., 1996).  
 
Another method to direct cES cells to differentiate in vitro is to culture them on 
a low-adherence substrate in media depleted from growth factors that maintain 
proliferation (Doetschman et al., 1985). Under such conditions chick 
embryonic stem cells form three-dimensional structures similar to mammalian 
embryoid bodies (EB) (Pain et al., 1996). After being in the EB state in low-
adherent culture dishes for a few days, cES cells are plated again on 
conventional tissue culture dishes where they spread and differentiate into 
cells of several lineages (Pain et al., 1996). Addition of chemicals such as 
retinoic acid can promote differentiation into a neural fate (Pain et al., 1996) 
which is accompanied by downregulation of markers such as Nanog and 
PouV/Oct3/4 (Lavial et al., 2007) 
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1.2.2.3. Chimaera formation and germ line transmission 
 
Injection of chick blastodermal cells into early embryos to make chimaeras 
was first done successfully many decades ago (Marzullo, 1970). This was 
repeated in different studies which confirmed that these blastodermal cells 
have the ability to contribute to somatic tissues as well as to the germ line 
(Carsience et al., 1993). Cultured cES cells can produce somatic chimeras 
with good efficiency (Pain et al., 1996) (See Table 1). However, the ability of 
blastodermal cells to contribute to the germ line is lost when these cells are 
cultured in vitro (Lavial and Pain, 2010; Pain et al., 1996; Petitte et al., 2004; 
Van de Lavoir et al., 2006a; Van de Lavoir et al., 2006b; Van de Lavoir and 
Mather-Love, 2006). 
 
1.2.2.4. Molecular characteristics 
 
Chick ES cells share many molecular characteristics with their mammalian 
counterparts (See Table 1) (Adewumi et al., 2007; The National Institute of 
Health, 2010). They include reactivity with antibodies raised against the mouse 
stage specific embryonic antigens (SSEA) 1, 3 and 4 (Knowles et al., 
1978;Pain et al., 1996;Shevinsky et al., 1982;Solter and Knowles, 1978). 
These are used as markers for mammalian stem cell differentiation; for 
example, SSEA-1 is expressed in mouse embryonic stem (ES) cells and this 
expression decreases when cells are induced to differentiate (Kudo and 
Narimatsu, 1995). SSEA-3 and SSEA-4 are not present in proliferating mouse 
ES cells but are markers of the self-renewing state in human stem cells, where 
expression decreases with cell differentiation (Shevinsky et al., 1982). Other 
markers of chick ES cells that are shared with mammalian pluripotent stem 
cells include alkaline phosphatase activity (Lawson and Hage, 1994; Pain et 
al., 1996), and expression of mRNA for PouV(Oct3/4) and Nanog (Lavial et al., 
2007) and Sox2 (Bertocchini et al., 2010b) see below. 
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1.2.2.5. Transgenesis and prospects for genetic modification 
 
The original aim of seeking methods for transgenesis of the domestic fowl was 
to create a bio-factory to produce biomedically valuable proteins in large 
quantities from egg albumen (Harvey and Ivarie, 2003; Ivarie, 2006; Sang, 
2004). To date there has been only one successful attempt at gene 
replacement by homologous recombination in cES cells (Acloque et al., 2001). 
Other methods mainly rely on random integration of injected or transfected 
DNA or using a viral vector, to achieve transgenesis.  
 
Some methods for generating transgenic birds have succeeded and several 
proteins have been generated this way including bacterial β-lactamase 
(Harvey et al., 2002) and human interferons (Rapp et al., 2003). Methods 
which have been used successfully to produce transgenic birds include 
microinjection of DNA into the early embryo (Love et al., 1994) and 
transfection by retroviruses or lentiviruses (Bosselman et al., 1989; Salter et 
al., 1987; Sang, 2004). Using the latter method, there are now lines of 
transgenic domestic fowl that ubiquitously express GFP (McGrew et al., 2004; 
Sang, 2004) and which have been used for example to follow cell lineage by 
transplantation, including a compelling demonstration that the tail bud of the 
early embryo contains endogenous stem cells that appear to be able to self-
renew indefinitely, as serial transplants of the tail bud through 3 host embryos 
continue to generate axial and paraxial tissue (McGrew et al., 2008). 
 
A few attempts have been made to generate transgenic chick ES cells using 
simple expression vectors (Pain et al., 1999) as well as gene trap vectors 
(Acloque et al., 2001). Other delivery systems can also be used to introduce 
transgenes into chick ES cells, such as cationic lipid-mediated DNA delivery 
which is now a standard transfection technique for cultured cells (Felgner et 
al., 1987; Felgner et al., 1989). However since it has not yet been possible to 
obtain contribution of ES cells to the germ line, these transgenic ES cell lines 
cannot yet be used to generate transgenic animals.  
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Table 1: Characteristics of ES cells in mouse, human and chick models 
 
ES characteristics§ Mouse Human Chick Chick Reference 
‘Stem’ state markers     
SSEA-1 Yes No Yes Pain et al., 1996 
SSEA-3 No Yes Yes Pain et al., 1996 
SSEA-4 No Yes Yes Pain et al., 1996 
Sox2 Yes Yes Yes Bertocchini et al.,  
(In prep) 
Oct3/4 Yes Yes Yes Lavial et al., 2007 
Nanog Yes Yes Yes Lavial et al., 2007 
Enzymatic Activity     
Alkaline Phosphatase Yes Yes Yes Pain et al., 1996 
In vitro culture requirement     
Feeder cells dependent Yes No Yes Pain et al., 1996 
LIF dependent Yes No Yes Pain et al., 1996 
Other characteristics     
Teratoma formation in vivo Yes Yes Yes Petitte & Yang 
2004 
Embryoid bodies formation Yes Yes Yes Pain et al., 1996 
Tight rounded colonies Yes No Yes Pain et al., 1996 
Loose flat aggregates No Yes Yes Pain et al., 1996 
§Mouse and human data are based on the characterization of human 
embryonic stem cell lines by the International Stem Cell Initiative (Adewumi et 
al., 2007). A comprehensive and up to date list of ES cells markers can be 
found on the official National Institute of Health resource for stem cell 
research: Appendix E: Stem Cells Markers (The National Institute of Health, 
2010). 
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1.3. Molecular regulation of self-renewal and 
pluripotency 
 
The concept of totipotency/pluripotency slightly predates the first definition of 
stem cells. Its beginning stems from the classical embryological experiments 
done by (Driesch, 1891) on sea urchin. He showed that when a 2-cell-stage 
sea urchin embryo is cut in half it will develop into two complete larvae. This 
work was repeated in newt embryos of up to 16 blastomeres (Spemann, 
1902). Totipotency is the ability of a cell to create any cell type or even an 
entire organism (Andrews et al., 2001). Pluripotency defines a cell that is able 
to give rise to many, but not all, embryonic tissues.  
 
There is considerable interest in elucidating the mechanisms required to 
maintain pluripotency of ES cells, both for many potential biomedical 
applications related to tissue regeneration and to understand the mechanisms 
of commitment and differentiation and suppression of neoplasia. The following 
sections outline some factors and pathways that influence self-renewal and 
pluripotency in embryonic stem cells. 
1.3.1. LIF pathway 
 
An early finding was the discovery that activation of a cytokine pathway can 
alter both cell proliferation and potency. Sustained proliferation of mouse ES 
cells and the maintenance of the undifferentiated state in vitro was shown to 
be highly dependent on the leukaemia inhibitory factor (LIF; also known as 
differentiation inhibitory activity, Dia) (Niwa et al., 1998; Smith and Hooper, 
1987). However it appears that LIF cannot prevent differentiation and support 
proliferation of human ES cells (Sato et al., 2004). Other factors are also 
required for sustaining pluripotentiality of ES cells in both species (Dani et al., 
1998). Interestingly, in vivo studies confirmed that LIF is not required for pre-
gastrulation mouse development (Nichols et al., 2001). This reminds us that 
embryonic stem cells are the product of in vitro culture, and that there is 
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probably no cell in the normal embryo at any stage that is entirely equivalent to 
an ES cell 
1.3.2. Oct3/4 and its chick homologue POUV  
 
Pluripotency of mouse ES cells seems to be tightly controlled by the POU 
transcription factor Oct3/4. The expression pattern of mouse Oct3/4 is limited 
to pluripotent cells (Pesce et al., 1998). During establishment of ES cell 
cultures from mouse embryos, this transcription factor is important for setting 
aside pluripotent founder cells (Nichols et al., 1998). If Oct3/4 expression is 
maintained at a critical level, it can prevent ESCs from differentiation upon 
withdrawal of LIF (Niwa et al., 2000). Several target genes have been 
identified for Oct3/4 in ESCs but little insight has emerged concerning their 
relevance to the regulation of multipotency (Niwa, 2001). POU family members 
act as transcriptional repressors or activators depending on a partnership with 
co-factors. Several co factors of Oct3/4 have been identified in the context of 
pluripotency regulation including adenovirus E1A which works as bridging 
factor between Oct3/4 and the basic transcription machinery (Scholer et al., 
1991) and Sox2. The Oct3/4-Sox2 complex then auto controls the transcription 
of each of he two partners (Tomioka et al., 2002). In addition to this auoto-
regulatory loop, the Oct3/4-Sox2 complex regulates several other target genes 
through differential enhancer activity (Botquin et al., 1998; Nishimoto et al., 
1999; Nishimoto et al., 2005; Yuan et al., 1995). 
 
In chick it was thought for a long time that there was no true homologue of 
Oct3/4 (Soodeen-Karamath and Gibbins, 2001). However more recently a 
gene named POUV was identified as the chick Oct3/4 homologue by 
sequence homology, synteny and functional conservation, since it can rescue 
mouse ES cells deprived of Oct3/4 (Lavial et al., 2007). 
1.3.3. Nanog 
 
Another key factor in the maintenance of self-renewal and pluripotency was 
identified relatively recently (Chambers et al., 2003). This gene encoding a 
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homeodomain-containing transcription factor was shown to maintain mESCs 
cell-renewal and pluripotency independently of LIF. The independent cloning 
of Nanog (Or Tir Na Nog, after the mythological Celtic land of the ‘ever young’) 
and subsequent functional analysis was a re-discovery of the function of this 
gene which has been originally described by another group which did not 
relate its function to stem cell self-renewal or pluripotency (Wang et al., 2003).  
 
Although undifferentiated ESCs express Nanog, its normal levels do not 
prevent ES cell differentiation after withdrawal of feeders (Yasuda et al., 
2006). Nanog seems to be one of several factors that are expressed in 
pluripotent cells and are downregulated during differentiation. Interestingly, 
Nanog was not among a group of 532 genes identified as being expressed in 
human ES cells (Brandenberger et al., 2004). Nanog expression was found to 
be responsible for the maintenance of the primitive ectoderm in the mouse 
embryo (Mitsui et al., 2003). In vitro, Nanog deficient mouse ES cells 
differentiate slowly into extra-embryonic endoderm lineages, which is 
consistent with the absence of a primitive ectoderm in Nanog–/– embryos 
(Mitsui et al., 2003). A similar induction of extraembryonic lineages is observed 
in ES cells following downregulation of Nanog in vitro (Darr et al., 2006b; 
Hyslop et al., 2005; Yates and Chambers, 2005). Over-expression of Nanog 
renders mouse ES cells resistant, but not completely refractory, to 
differentiation following LIF withdrawal or chemical induction (Darr et al., 
2006a). The persistence of Nanog therefore seems to delay and increase the 
threshold rather than blocking ES cell differentiation.  
 
Similar to Oct4, the level of Nanog per cell was found to be crucial for stable 
maintenance of an undifferentiated state; the reduced expression seen in 
Nanog+/- ES cells results in spontaneous differentiation after longer culture 
times (Hatano et al., 2005). Another similarity with Oct4 is the proposal that 
the Nanog acts by repressing the transcription of differentiation-promoting 
genes, suggested because Nanog-binding sites can be found in the control 
regions of genes like Rex1/Zfp42 (Mitsui et al., 2003).  
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An interesting finding on the regulation of Nanog concerns its relationship to 
the tumour suppressor p53, which binds to the Nanog promoter to maintain 
genetic stability of ES cells (Lin et al., 2005; Xu, 2005). Loss of p53 leads to a 
100-fold increase in susceptibility to testicular teratoma which was proposed to 
be due partly to the repression of genes such as Nanog (Lin et al., 2005). And 
finally, Nanog was shown to interact with Smad1 to block BMP induced 
differentiation of ES cells: A gate keeper to the ES cells multipotent ‘stem’ 
state (Sun et al., 2006; Suzuki et al., 2006). 
1.3.4. Sox2 
 
Sox2 is a transcription factor (TF) belonging to the SoxB1 subfamily of genes 
(Miyagi et al., 2009). Sox proteins are characterised by the presence of an 
SRY-related high mobility group (HMG) box and act as transcription factors, 
probably able to cause physical bending of DNA. During early mouse 
development, Sox2 is first expressed in 2 sites and stages: first, it is 
expressed in the Inner Cell Mass (ICM) where its role was proposed to 
maintain cells in undifferentiated state (Wegner, 1999; Wood and Episkopou, 
1999). Second, Sox2 is considered a general marker for the early neural plate 
(Graham et al., 2003; Rex et al., 1997a; Uwanogho et al., 1995; Wood and 
Episkopou, 1999; Zappone et al., 2000). Gene targeting experiments have 
revealed that Sox2 is required for very early embryonic development: Sox2 
null mutant mice fail to develop beyond implantation (Wegner, 1999). 
 
Sox2 is also expressed in at least three types of stem cells: neural, embryonic 
(ES cells) and trophoblast stem cells (Wiebe et al., 2000; Yuan et al., 1995). 
Sox2 is thought to be involved in maintaining pluripotency through its 
partnership with Oct3/4 (Chickarmane et al., 2006). This complex works as 
transcriptional activator for many genes implicated in maintaining pluripotency 
of ES cells such as  FGF-4 and  Fbxo15 (Tokuzawa et al., 2003) and Lefty1 
(Nakatake et al., 2006). Through this mechanism the Sox2-Oct3/4 complex 
also regulates transcription of Nanog (Kuroda et al., 2005; Rodda et al., 2005). 
Furthermore, both Sox2 and Oct3/4 have regulatory regions with binding sites 
which are activated by the Sox2-Oct3/4 complex, which may define a positive 
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feedback loop involved in the maintenance of pluripotency in ES cells (Chew 
et al., 2005; Tomioka et al., 2002). Work on mouse ES cell pluripotency and 
differentiation demonstrated that factors that compete with Sox2 in binding to 
Oct3/4 are able to break this regulatory feedback loop leading to the exit of ES 
cells from the pluripotent self-renewing state and inducing differentiation (Niwa 
et al., 2005). 
 
However, Sox2 appears to act redundantly with other factors in regulating 
transcription of pluripotency-maintaining factors: inducible Sox2-/- mutant ES 
cells have normal expression of such genes (Fgf4, Oct3/4, Nanog) (Masui et 
al., 2007). Nevertheless, these Sox2-null ES cells fail to maintain pluripotency 
and display alteration in the expression of factors that act upstream of Oct3/4 
suggesting that the main role of Sox2 in ES cells is the maintenance of critical 
levels of Oct-3/4 expression. (Gu et al., 2005; Schoorlemmer et al., 1994). 
This could explain why Sox2 is not essential to maintain pluripotency when 
Oct3/4 levels are increased experimentally (Masui et al., 2007). 
 
Studies in a broad range of eukaryotes have shown that transcriptional 
regulators that have key roles in cellular processes frequently regulate other 
regulators of the same processes (Guenther et al., 2005; Odom et al., 2004). It 
is likely that the key stem cell regulators bind and regulate genes encoding 
other transcriptional regulators, which in turn determine the developmental 
potential of these cells. We still lack sufficient knowledge of the regulatory 
circuitry of ES cells and of embryonic cells during development to understand 
this complex regulation fully. 
1.3.5. iPS cells 
 
A major recent discovery in stem cell research took place a few years ago 
when it was found that ES-like cells could be derived from tissues other than 
the inner cell mass of the early embryo. Mouse embryonic fibroblasts could be 
converted to cells with similar characteristics to ES cells by introducing just 
four transcription factors: Oct-3/4, Sox2, Klf4, and c-Myc. Cells so transformed 
were named Induced Pluripotent Stem (iPS) Cells (Takahashi and Yamanaka, 
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2006). Later it was discovered that iPS cells can be derived from human adult 
differentiated skin cells (Takahashi et al., 2007). The discovery that even adult 
somatic cells can be induced to acquire pluripotency and self-renewal 
comparable to those of embryonic stem cells immediately raised hopes that 
embryonic cells may become unnecessary for therapeutic applications, 
removing ethical objections raised by the general public and many religious 
groups as well as potentially offering a solution to immunological problems 
(potential rejection of heterologous cells)(Takahashi et al., 2007; Yamanaka, 
2007). 
 
1.4. Molecular mechanisms of neural 
specification 
 
1.4.1. Neural Induction 
 
Perhaps one of the most striking discoveries in developmental biology is the 
response of the ectoderm of the prospective belly of amphibian embryos to a 
graft of the dorsal lip of their gastrula blastopore – this results in the formation 
of an entire second axis containing a complete central nervous system derived 
from the host ectoderm. This experiment by Hilde Mangold and Hans 
Spemann (Spemann and Mangold, 1924) first demonstrated neural induction, 
as well as defining the “organizer” as an important embryonic signalling centre. 
The concept of embryonic induction i.e. an instructive interaction between two 
neighbouring tissues in which one changes its direction of differentiation in 
response to signals from the other, was proposed almost a century before 
Spemann and Mangold (von Baer, 1828) but lacked direct experimental 
demonstration. Moreover, Lewis (1907) had also previously shown that a 
secondary axis develops after grafting the dorsal lip of the blastopore. 
However, Lewis was unable to distinguish graft and host cells, a problem 
resolved by the use of interspecific grafts between differently pigmented newts 
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by Spemann and Mangold, which enabled them to show that the secondary 
axis originates from the host rather than from the graft. 
 
Soon, other vertebrate Classes including birds (Waddington, 1932), teleosts 
(Luther, 1935; Oppenheimer, 1936) and mammals (Waddington, 1936; 
Waddington, 1937) were also shown to possess a region with similar activity to 
Spemann’s organizer. Furthermore, organizers from a different Class can 
induce neural tissue. Chick Hensen’s node (the functional equivalent of 
Spemann’s organizer) grafts can induce a neural plate in fish(Hatta and 
Takahashi, 1996), amphibians (Kintner and Dodd, 1991) and mammals 
(Waddington, 1934). Likewise, rabbit nodes can induce neural tissue in birds 
(chick or duck) (Waddington, 1936; Waddington, 1937; Zhu et al., 1999). 
These interspecies transplantation experiments strongly suggest that the 
neural inducing signals are common to different vertebrates, suggesting 
conservation of the molecular mechanisms of neural induction. 
 
The first molecular explanation for neural induction regulation came from the 
discovery that bone morphogenetic proteins (BMP) act as inhibitors of neural 
fate in Xenopus. Three genes, Noggin (Lamb et al., 1993), (Hemmati-
Brivanlou et al., 1994) and Chordin (Sasai et al., 1994) expressed in the 
amphibian organizer were found to have a neuralizing activity through 
inhibition of BMP (Piccolo et al., 1996; Zimmerman et al., 1996). 
 
These findings soon led to the ‘default’ model of neural induction. This model 
suggests that cells in amphibian ectoderm have an inherent ‘default’ tendency 
to become neural tissue, which is inhibited by BMP. BMP inhibitors secreted 
by the organizer lower the effective concentration of BMP in the dorsal 
ectoderm, allowing these cells to acquire a neural fate, whereas BMP 
concentration would remain high in more distant ventral regions, where the 
ectoderm becomes inhibited from assuming a neural fate and instead 
differentiates into epidermis (Hemmati-Brivanlou and Melton, 1997). 
 
The wide distribution of BMP4 transcripts in the Xenopus blastula stage 
ectoderm (Fainsod et al., 1994), and the neuralization of Xenopus animal caps 
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when they are either injected with dominant-negative BMP receptors (Sasai et 
al., 1995; Xu et al., 1995), or treated with BMP antagonist Chordin and Noggin 
(Lamb et al., 1993; Sasai et al., 1995) as well as the dramatic loss of neural 
tissue and increase in skin formation when three of BMP antagonist (Chordin, 
Noggin, Follistatin) are depleted from Xenopus embryos (Khokha et al., 2005) 
all support the default model of neural induction. 
 
Other work in Xenopus challenged the default model. BMP antagonist cannot 
neuralize ectoderm if Fibroblast growth factor (FGF) signalling is inhibited 
(Delaune et al., 2005b; Launay et al., 1996; Linker et al., 2009; Linker and 
Stern, 2004; Sasai et al., 1996). In the chick, neither BMPs nor their 
antagonists Chordin, Noggin or Follistatin are expressed in accordance with 
the predictions of the default model, misexpression of BMP cannot inhibit the 
expression of the early neural marker Sox3 in the neural plate and 
misexpression of BMP antagonists is not sufficient to induce neural tissue in 
competent ectoderm (Linker et al., 2009; Linker and Stern, 2004; Streit et al., 
1998; Streit et al., 2000; Streit and Stern, 1999a; Streit and Stern, 1999b). 
These observations suggest that BMP antagonism is not sufficient for neural 
induction. 
 
FGF signalling was implicated in neural induction by experiments in Xenopus 
showing that BMP antagonist fail to induce neural tissue under conditions 
blocking FGF signalling (Launay et al., 1996; Pera et al., 2003; Sasai et al., 
1996), although findings from other groups made this controversial [eg (Amaya 
et al., 1991)]. Likewise in the chick several groups claimed that FGF was 
sufficient for neural induction (Alvarez et al., 1998; Henrique et al., 1997). 
 
Eventually, through the cloning and characterisation of a very early marker for 
neural induction, ERNI, it was proposed that neural induction begins through 
FGF signalling even before gastrulation; moreover, inhibition of FGF signalling 
renders Hensen’s node unable to neuralize competent epiblast (Streit et al., 
2000). Time course experiments where an organizer was grafted, removed at 
various times and replaced by a graft of chordin (BMP-antagonist) secreting 
cells showed that BMP inhibition can stabilize the expression of early neural 
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markers induced by 5 hours’ exposure to signals from the organizer, but 
cannot by itself induce neural tissue (Streit et al., 1998; Streit et al., 2000; 
Streit and Stern, 1999b). That FGF signalling is involved in initiating neural 
induction before gastrulation was also proposed by Wilson and Edlund (2000; 
2001) based on the results of explant culture experiments. 
 
It was then discovered that activation of the MAP kinase (MAPK) pahtway by 
FGF signalling can downregulate BMP targets via phosphorylation of the linker 
region of Smad1 reopened the controversy and questioning the independent 
role of FGFs in neural induction (De Robertis and Kuroda, 2004). However 
further work confirmed that FGF signalling is required for neural induction in 
both chick and Xenopus independently from its effects on BMP inhibition 
(Aubin et al., 2004; Delaune et al., 2005a; Linker and Stern, 2004). 
 
Wnt signalling has also been implicated in neural induction in a paradoxical 
way. Studies in Xenopus suggested that Wnt activation is required for neural 
induction by inhibiting BMPs (Baker et al., 1999). However work using chick 
epiblast explants suggested that Wnt inhibition is required for FGF to induce 
neural tissue in epiblast cells as cells expressing or exposed to Wnt signalling 
take on epidermal fate (Wilson et al., 2001), a finding also supported by other 
experiments in Xenopus (Delaune et al., 2005a; Heeg-Truesdell and LaBonne, 
2006). These paradoxical results could be explained by considering the timing 
of Wnt signalling during embryonic development. At very early stages, Wnt 
signalling is required specify the dorso-ventral axis of the embryo and help to 
position the organiser: high levels of Wnt specify dorsal fates. At a later stage 
Wnt signalling may have an antagonist effect on neural induction (Delaune et 
al., 2005a; Wilson et al., 2001). 
 
Neural induction also involves other mechanisms and proteins. Churchill, a 
zinc finger transcriptional activator induced by FGF, was found to regulate cell 
choice between mesoderm and neural fate at the end of gastrulation (Sheng et 
al., 2003). Through its target genes (Sip 1: Smad-interacting protein 1 in chick 
and Xenopus and δ-EF1 in the mouse) (Miyoshi et al., 2006; Sheng et al., 
2003; Snir et al., 2006) and interaction with POU domain genes (Nitta et al., 
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2004) Churchill blocks expression of genes required for mesoderm formation 
such as Brachyury and Tbx6L, which stops the ingression of cells through the 
primitive streak at the end of gastrulation ensuring that the future neural plate 
remains on the surface. 
 
Notch signalling (Yoon and Gaiano, 2006), POU transcription factors (Matsuo-
Takasaki et al., 1999; Tanaka et al., 2004; Witta et al., 1995), as well as 
complex interactions between coiled-coil domain proteins (ERNI, Geminin and 
BERT), the heterochromatin proteins HP1α and HP1γ acting as repressors 
and the chromatin remodelling enzyme Brm acting as activator (Papanayotou 
et al., 2008) were all found to have roles in neural induction. Specification of 
embryonic epiblast cells to a neural plate fate is therefore the result of 
progressive decisions in response to a complex cascade of different signals 
(Stern, 2006). 
1.4.2. Induction of neural differentiation in cultured ES 
cells 
 
In vitro, ES cells can be induced to differentiate into neurons (Bain et al., 1995; 
Fraichard et al., 1995; Strubing et al., 1995). Several different protocols are 
available to direct ES cell cultures to a neural fate (Abranches et al., 2009; 
Studer, 2004). However we still have no idea whether commitment and 
differentiation to neural fates of these cells is an equivalent process to, or 
whether it is controlled by similar mechanisms than, neural induction in normal 
embryos. 
 
For a relatively long period following the early reports, induced neural 
differentiation of ES cells was achieved by a two step method involving 
culturing the cells in suspension in low adhesion culture plates to form 
aggregates called embryoid bodies (EB) first, then plating them on 
conventional tissue culture dishes (Doetschman et al., 1985). This method 
directs ES cells through the complex interactions taking place within cells of 
the EB to differentiate into derivatives of all three embryonic germ layers 
(Doetschman et al., 1985). 
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To direct ES cells to a neural fate, EBs were grown in several conditions that 
seem to promote neural differentiation rather than differentiation into 
mesoendodermal lineages. EB were treated with various concentrations of 
retinoic acid (RA) (Bain et al., 1995) then plated on substrates that appear to 
promote neural or glial cell types such as gelatine (Strubing et al., 1995) or 
laminin (Bain et al., 1995). The result is rich networks of cells with neuronal 
morphology, expression of neural-specific proteins and electrical and chemical 
functionality (Bain et al., 1995; Liu et al., 2000). The mechanism through which 
RA can direct EB cells to a neural fate is not yet understood but may be 
related to its role in anterior-posterior patterning of the embryo through Hox 
genes (Krumalauf 1994) or to the recently discovered antagonism of FGF 
signalling by retinoids (Diez Del Corral et al., 2003).  
 
Another successful enhancement of neuronal differentiation efficiency in EB 
based protocols was achieved by culturing cell aggregates in the 
hepatocarcinoma cell line (HepG2) (Rathjen et al., 2002). The result is 
absence of cells expressing mesoendodermal markers and a progeny 
expressing neural progenitor markers such as Nestin, Sox1 and Sox3. The 
mechanism by which HepG2 cells direct induced differentiation has not been 
identified (Rathjen et al., 2002).  
 
Finally, a third strategy to enhance induced neural differentiation of EBs was 
described, based on growing EB in selective low serum-containing medium 
(Brustle et al., 1999; Lee et al., 2000; Okabe et al., 1996). Under these 
conditions most of the EB cells die and a small number of Nestin rich cells 
survives. The Nestin rich progeny could then be expanded and further directed 
to neuron-specific sub population by addition of factors with developmentally 
identified roles (See below).  
 
An alternative to using EB cells relied on culturing ES cells on monolayers of 
bone marrow derived stromal cells (PA-6 line) (Kawazaki et al., 2000). This 
method of differentiation direct ES cells to differentiate into dopaminergic 
neurons by unidentified mechanisms (Barberi et al., 2003; Kawazaki et al., 
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2002). However, as this neural effect is still seen when ES cells are cultured 
on fixed stromal cells, it has been proposed that induced neural differentiation 
is mediated through a cell surface mechanism rather than as a result of the 
production of cytokines by the feeder cells (Kawazaki et al., 2002). 
 
Another method to induce neural differentiation is to culture ES cells on 
nonadherent (Tropepe et al., 2001) or adherent (Ying et al., 2003) substrates 
in the absence of feeder cells. A pre-requisite of this method is to grow ES 
cells in serum free in the absence of BMP signalling (Ying et al., 2003). 
Furthermore, ES cells derived from embryos in which components of the BMP 
pathway has been knocked out had almost a four-fold increase in induced 
neural differentiation suggesting that neural differentiation can be inhibited by 
BMP (Tropepe et al., 2001). This induced neural differentiation was shown to 
be dependent on FGF signalling. Blocking FGF signalling pharmacologically or 
using a dominant negative approach prevents neural differentiation of ES cells 
similar to what has been found in neural induction in the embryo (Streit et al., 
2000). 
 
Addition of factors to the basic medium has been used to study the effects of 
signalling pathways including Notch (Lowell et al., 2006), BMP (Tropepe et al., 
2001) and FGF (Ying et al., 2003). Monolayer culture-based induced neural 
differentiation avoids the use of serum (Brewer et al., 1993; Ying et al., 2003; 
Ying and Smith, 2003) and the complex unidentifiable cell-cell interactions of 
other methods providing a useful system to define essential molecular 
mechanisms required to specify cell fate. 
 
Altering the basic three methods of induced neural differentiation discussed 
above by adding signals known to control specific early patterning events in 
the embryo successfully led to directing ES cell differentiation into specific cell 
types. It was thus possible to direct ES cell induced neural differentiation into 
dopaminergic (Kawazaki et al., 2002; Lee et al., 2000; Ying et al., 2003), 
serotonergic (Kim et al., 2002), motor (Barberi et al., 2003; Mizuseki et al., 
2003; Wichterle et al., 2002), GABAergic (Bain et al., 1995; Barberi et al., 
2003) or glutamatergic neurons (Bain et al., 1995; Strubing et al., 1995) as 
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well as into several types of glial cells (Barberi et al., 2003; Brustle et al., 
1999). 
1.5. Sox2 and the SoxB1 family in neural 
development.  
 
Sox (SRY-related HMG box) genes comprise a family of about 30 genes 
identified in relation to their role in sex determination in the male (SRY: sex-
determining region of Y chromosome) (Kiefer, 2007; Wegner and Stolt, 2005). 
In mammals proteins encoded by these genes are organised into 8 groups, 
named A-H. This division is based on the phylogenetic characteristics of a 
highly conserved 79-amino acid high mobility group (HMG) box domain with 
sequence-specific DNA binding function (Bergstrom et al., 2000; Dailey and 
Basilico, 2001; Soullier et al., 1999).These proteins bind to DNA in a sequence 
specific manner and act as either activators or repressors of transcription of 
other proteins (Ambrosetti et al., 1997; Ambrosetti et al., 2000; Catena et al., 
2004; Kamachi et al., 2001; Krstic et al., 2007; Mojsin and Stevanovic, 2010; 
Tsuruzoe et al., 2006). 
 
The second group (B) is divided into two subgroups: SoxB1, which comprises 
the transcription factors Sox1, Sox2, and Sox3 and SoxB2 which includes 
Sox14 and Sox 21 (Holmberg et al., 2008; Miyagi et al., 2009). The SoxB1 
subfamily of transcription factors has been implicated in many developmental 
processes as regulator of cell fate decisions [reviewed by (Miyagi et al., 
2009)]. Here, their role in neural development is discussed with a focus on 
Sox2. 
 
In addition to its expression in the early epiblast of vertebrate embryos 
(Graham et al., 2003; Wood and Episkopou, 1999; Zappone et al., 2000) Sox2 
is also expressed in the early neural plate (Collignon et al., 1996; Graham et 
al., 2003; Rex et al., 1997a; Uwanogho et al., 1995; Wood and Episkopou, 
1999; Zappone et al., 2000). Sox2 is considered one of the earliest definitive 
markers for the neural plate (Albazerchi and Stern, 2007; Linker and Stern, 
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2004; Papanayotou et al., 2008). In addition to the timing and extension of 
expression domain itself, time-course experiments have revealed that Sox2 is 
induced after exposure to organizer-derived signals after a period of time 
similar to that required to induce a mature neural plate (Bainter et al., 2001; De 
Robertis and Kuroda, 2004; Stern, 2005a; Streit et al., 1998; Streit and Stern, 
1999a) . 
 
Expression of the other SoxB1 group members (Sox1 and Sox3) overlap 
extensively with Sox2 in the developing CNS in both rodents and birds 
(Graham et al., 2003; Pevny et al., 1998; Uwanogho et al., 1995; Wood and 
Episkopou, 1999). It is therefore difficult to get insight into a differential role of 
the SoxB1 family members based on their expression patterns.  
 
All members of the SoxB1 family have been targeted by loss of function 
(‘knock out’) experiments. Sox1 homozygous mutants live and display no 
major CNS abnormalities apart from lens defects (Malas et al., 2003). In 
contrast, loss of Sox2 or Sox3 lead to embryo lethality (Rissoti et al., 2004; 
Wegner, 1999). 
 
Induced loss of Sox2 function in mouse embryos shortly after gastrulation 
reveals its essential role in the development of the anterior CNS and the retina 
as embryos lacking its expression at this stage develop with enlarged lateral 
ventricles of the cerebrum (Graham et al., 2003) and complete loss of 
proliferation and differentiation of neural retinal progenitor cells (Taranova et 
al., 2006). The defects caused by the loss of Sox2 function can be rescued by 
expression of Sox. Furthermore, the level of Sox3 expression was elevated in 
the Sox2 mutant embryos, suggesting possible partial functional compensation 
by other SoxB1 genes upon loss of Sox2 (Bylund et al., 2003; Ferri et al., 
2004) 
 
Conditional Sox3 loss of function leads to a spectrum of phenotypes (about 
one third of embryos appear normal). Defects observed in abnormal embryos 
include problems in the development of the hypothalamo-pituitary axis (Rissoti 
et al., 2004). 
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The defects observed in different aspects of CNS development, especially in 
the developing eye where the overlap between Sox1, 2 and 3 is less than that 
in rest of the CNS, gives a unique insight of the differential and redundant 
functions between SoxB1 proteins. Sox3 is never expressed in the lens, and 
Sox2 expression is restricted to early stages of lens development. This 
functional redundancy between members of the SoxB1 family appear to be a 
conserved biological process from fly to mammals (Ferri et al., 2004; Graham 
et al., 2003; Overto et al., 2002; Wegner, 1999). 
 
In cultured cells, Sox2 is important for the differentiation of embryonic neural 
stem cells into mature neurons whereby neural progenitors derived from Sox2 
knocked down embryos fail to differentiate into mature MAP-2 positive cells in 
a way that could be rescued by over expression of Sox2 (Cavallaro et al., 
2008). 
 
Two fundamental characteristics of SoxB1 group regulatory mechanisms have 
already been revealed. First: Sox proteins bind to other transcription factors to 
form complexes to regulate many target genes during development (Kamachi 
et al., 2000). Examples of this include the Sox2-Oct3/4 complex which 
maintains the stem state of ES cells (see above) and the interactions between 
Sox2 and Pax6 in eye development (Inoue et al., 2007).  
 
Second, the expression of these transcriptional factors (as shown for Sox2) is 
regulated by multiple enhancers which are activated by specific factors in 
different cell types and distinct stages of embryo development (Uchikawa et 
al., 2003). These enhancers are highly conserved between vertebrate species 
(Uchikawa et al., 2003; Wegner, 1999).  
 
Five enhancers (named N1-N5) are responsible for directing Sox2 expression 
to different parts of the CNS at different times in development (Kamachi et al., 
2009; Kondoh and Uchikawa, 2008; Uchikawa et al., 2003). In the chick 
embryo, the N2 enhancer controls Sox2 expression in the early anterior neural 
plate when Sox2 expression marks commitment to a neural plate fate 
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(Uchikawa et al., 2003). The same N2 enhancer was found to activate Sox2 
transcription in proliferating ES cells as well as mouse neural progenitor cells 
in the mouse embryo (Miyagi et al., 2004; Tomioka et al., 2002; Zappone et 
al., 2000). In mouse ES cells it was demonstrated using gel shift assays that 
Oct3/4 binds to this site to activate Sox2 transcription (Catena et al., 2004; 
Tomioka et al., 2002; Zappone et al., 2000), whereas the related POU factors 
Brn1/2/4 and Oct-6 activate Sox2 mRNA expression in the mouse embryo 
nervous system (Catena et al., 2004). 
 
Analysis of the N2 enhancer identified multiple putative binding sites for known 
transcription factors (Uchikawa et al., 2003; Uchikawa et al., 2004)( also see 
appendix 1). Recent functional experiments in the chick embryo revealed that 
Otx2 (Kamachi et al., 2009) and  a group of coiled-coil proteins interact with 
each other and with chromatin-remodelling factors and heterochromatin 
proteins to regulate the activity of the N2 enhancer to regulate the expression 
of Sox2 in precursors of the anterior neural plate (Kamachi et al., 2009; 
Papanayotou et al., 2008). Studies such as these allow dissection of the 
critical factors, and thereby the molecular networks responsible, for cell fate 
decisions during both normal embryonic development and in cultured 
pluripotent embryonic stem cells. 
 
1.6. Aims of this thesis 
 
Stem cells are emerging as an important tool to study biological processes, 
investigate the aetiology of disease and design pharmaceutical and cell based 
therapies (Smith, 2001). Among the diseases for which there is hope for the 
latter are neurological conditions, especially neurodegenerative disorders such 
as Parkinson’s disease where cell replacement could offer substantial hope 
(Chiba et al., 2008;Wernig et al., 2008).  
 
To harness the power of multipotent embryonic cells to generate neural tissue 
for transplantation, it is essential to understand the mechanisms directing their 
differentiation both during normal embryonic development and in cultures of 
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embryonic or adult-derived stem cells. In the embryo, we are only just starting 
to understand neural induction, which appears to be a complex multistep 
process. It is now believed to start before gastrulation and ends in the 
formation of the embryonic neural plate (Stern, 2004b; Stern, 2005a; Stern, 
2006). At the latter stage, expression of transcription factors of the SoxB1 
Class, and especially Sox2 and Sox1, represent good markers for this state as 
soon as the neural plate can be identified in the embryo (Collignon et al., 
1996; Ellis et al., 2004; Linker and Stern, 2004; Papanayotou et al., 2008; Rex 
et al., 1994; Rex et al., 1997b; Uwanogho et al., 1995). More recently it was 
discovered that Sox2 also plays a key role in regulating the self-renewal of ES 
cells (Avilion et al., 2003).  
 
Sox2 is expressed in many sites during development and at different stages 
(Wegner, 1999). Recent studies on how this complex expression is regulated 
have revealed that different aspects of its expression are controlled by 25 
highly conserved non-coding elements (Uchikawa et al., 2003). Between them, 
5 of these enhancers (N1-N5) account for the expression of Sox2 in the 
developing CNS. The remaining non-coding elements direct expression to 
other tissues especially components of the PNS, such as neural crest and 
placodes (Uchikawa et al., 2003). However we still know very little about the 
mechanisms that direct Sox2 expression in proliferating ES cells. 
 
It is difficult to study neural induction in the mouse, which develops in utero 
and cannot be cultured in vitro at peri-implantation stages. For this the chick 
has been a more useful model and much progress has been made recently as 
reviewed in (Stern, 2004b; Stern, 2005a; Stern, 2006). However ES cells had 
only been well characterised in the mouse. The relatively recent isolation of 
chicken embryonic stem cells (cES cells) (Pain et al., 1996) now allows the 
use of the same animal model to study neural induction and the regulation of 
Sox2 expression in vivo and in vitro. This project represents an initial 
characterisation of cES cells by studying the dynamics of their differentiation 
and the mechanisms responsible for Sox2 expression in the self-renewing 
(“stem”) state and during induced neural differentiation.  
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As this project is based on in vivo studies in the embryo (Catena et al., 2004; 
Uchikawa et al., 2003; Zappone et al., 2000), studying the regulation of Sox2 
in cES cells raises two fundamental questions: Is the process of induced 
neural differentiation of cES cells in any way comparable to neural induction in 
the embryo? Are these processes controlled by similar mechanisms?  
 
The aim of this project will, therefore, be to answer the following questions:  
 
1] What is/are the enhancer(s) which regulate Sox2 mRNA expression in cES 
cells during their prolifrative ‘self-renewal’ condition? 
 2] Can cES cells be differentiated into neurons in a way comparable to 
methods described in their mammalian counterparts? 
3] Given the hypothesis that cES cells can be induced into neuronal 
differentiation in vitro in a way similar to mammalian ES cells, would Sox2 
expression change during this induced neural differentiaion? 
4] What is/are the enhancer(s) which regulate Sox2 mRNA expression 
following induction of differentiation to a neural fate? 
 
To answer these questions, Chapter 1 has reviewed the literature by 
introducing ES cells in general with a focus on cES cells, regulation of the 
‘stem’ state, the ‘neural’ state as well as the neurodevelopmental role played 
by Sox2 and the rest of the members of SoxB1 family of transcription factors. 
.  
After describing the principal methods used in this project (Chapter 2), Chapter 
3 examines the activity of conserved non-coding genomic regions associated 
with Sox2 in proliferating cES cells and reveals the N2 enhancer as the most 
critical element. Chapter 4 compares different protocols for inducing cES cells 
to acquire a neural fate. Chapter 5 then follows the changes in Sox2 
expression as well as the activity of the N2 enhancer over a 10 day period 
following initial induction of neural differentiation. A further refinement of the 
region driving expression of Sox2 reveals a small core, both necessary and 
sufficient for the activity of the N2 enhancer. 
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Chapter 2. Methods 
 
2.1. Preparation of culture dishes and feeder 
cells 
 
The method used in extracting and maintaining cES cells is based on a a 
modified version of a patented method registered in the United States Patent 
and Trademark Office No. 5,340,740 (Petitte and Yang, 1994). Dishes (Becton 
Dickinson, USA) were coated with 0.1% gelatine in sterile water solution 
(Chemicon, USA). 2 ml of the gelatine solution were added to each well of a 6 
well dish, 1 ml/well for 12 well dish, 0.5 ml/well for 24 well dishes, and 0.3 
ml/well for 48 well dishes. The wells were incubated at room temperature for 
30 minutes, and the gelatine removed before use. 
 
STO feeder cells (American Type Culture Collection No. CRL 1503) were 
prepared by maintaining the cells at 37°C in 7.5% CO2 in DMEM containing 
10% FBS and 2 mM L-glutamine. The cells were treated with 10 µg/ml of 
Mitomycin C (Sigma) for 90 minutes at 37 °C, rinsed with PBS then detached 
from the culture dishes using 0.25% trypsin/0.025% EDTA solution 
(GIBCO™). The trypsin was inactivated by collecting the cells in DMEM with 
10% fetal bovine serum (FBS) and washed at 1100 rpm for 10 minutes. After 
washing, cells were resuspended in DMEM with 10% FBS and counted. The 
cells were then seeded on gelatinized plates as described above at a density 
of 1x105/cm2 and incubated for one to four days before use.  
2.2. Preparation of conditioned medium 
 
Stem cells were maintained in Buffalo Rat Liver (BRL) cell conditioned 
medium supplemented (See below) to make Embryonic Stem cell culture 
medium (ESA). First, BRL-3A cells (American Type Culture Collection No. 
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CRL 1442) are cultured and expanded in DMEM (GIBCO™, UK) containing 
10% FBS and 2 mM L-glutamine. After BRL cells were grown to confluence, 
the primary medium is replaced with knockout DMEM containing 5% FBS and 
2mM L-glutamine and cells cultured at 37°C in 5% CO2 for 3 days. The 
secondary (conditioned) medium was removed and two new batches of 
medium were conditioned for another 2 periods of 3 days each. The 
conditioned medium is then filtered and diluted to 50% or 80% with knockout 
DMEM with 15% FBS and this then supplemented with: 1 mM sodium 
pyruvate (GIBCO™ , UK), 1% MEM Non-Essential Amino Acids Solution 10 
mM (100X) (GIBCO™ ,UK), 1% MEM Vitamin Solution (100X) (GIBCO™ , 
UK), 1 mM of each nucleotide (adenosine, guanidine, cytosine, uridine, 
thymidine; Chemicon, USA), 0.16 mM b-mercaptoethanol (Chemicon, USA), 
100 U/ml penicillin and 100 mg/ml streptomycin (GIBCO™ , UK) to make up 
the embryonic stem cell culture medium (ESA). Media were stored at 4°C and 
used within 7 days. 
2.3. Generation of cES Cells from avian 
blastodermal cells 
 
Freshly laid unincubated eggs (Brown Bovan Gold; Stewart UK) were used. 
Embryos were staged according to (Eyal-Giladi and Kochav, 1976). Only 
embryos prior to the formation of the primitive streak - preferably at stage X-XI 
- were used to prepare the blastodermal cells. The entire blastoderm was 
removed and dissociated by gentle aspiration with a Pasteur pipette in 
phosphate buffered saline solution (PBS) at room temperature. Embryo 
dissociated blastodermal cells were then pooled at 1 embryo per ml and 
centrifuged at 400 g for 10 minutes. The cell pellet was then gently suspended 
in ESA complete medium. Cells were seeded at a final concentration of 1 
embryo per well in ESA complete medium on gelatine coated 48 well dishes 
which had been seeded with inactivated STO feeder cells. The blastodermal 
cells were maintained at 39°C in 7.5% CO2. One-quarter of the medium was 
replaced with fresh medium after 24 hours in culture. Half of the medium was 
then changed on the third day and all of it every day thereafter.  
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2.4. Maintenance of cES cells and cell lines 
 
Cryo-preserved cES Cells from established lines (see below) were thawed and 
maintained in culture according to published protocols (Pain et al., 1996, van 
de Lavoir and Mather-Love, 2006). The cells were grown on a STO feeder 
layer with a concentration of cES: STO of 10:1. The cES cells were cultured 
until 80–100% confluence before they were passaged in a 1:2 – 1:3 ratio. 
Usually, cultures were passaged daily. To maintain optimum growth and to 
prevent differentiation, the cells were passaged by transferring 25–30% of the 
medium covering the cells into the new well. The cells were then dispersed 
using either a short trypsin (0.25% trypsin/ EDTA solution diluted to 20% in 
PBS solution) wash or 1–2 min incubation in Ca/Mg free PBS and passaged 
as small clumps. The morphology of the cES cells was observed daily to 
confirm that they remained undifferentiated, using the criterion of a large 
nucleus with a prominent nucleolus and relatively little cytoplasm (Figure 2.1). 
 
Two established chicken embryonic stem cell lines were used: 9N2 (Acloque 
et al., 2001), 403 (Origen Therapeutics, Inc.1450 Rollins Road, Burlingame, 
California 94010, USA) and a primary line (30) which was generated and 
characterized in Professor Claudio Stern lab Ms. Sharon Boast in 2005. All 
three lines resemble murine and human embryonic stem cells (see Table 1) 
and can all be maintained as described above.  
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Figure 2.1: Morphology of cES cells: Three cES cell lines morphology is 
displayed at 10x, 20x and 20x objective lens magnifications. Following 
extraction of blastodermal cells from the epiblast of freshly laid eggs and 
culturing them for several days in ESA medium, the morphology of the cES 
cells is observed daily to confirm yield of primary cell line. A-C: Successful 
yield of a primary cES cells with typical characteristics of clumps of tear-drop-
like cells with prominent large nucleus and relatively little cytoplasm (arrows). 
These can easily be distinguished from large and flat feeder cells (asterisk)   
displaying characteristic clumps/clusters of cells with little cytoplasm, large 
nucleus and prominent nucleolus (arrow heads). These primary cES cells 
resemble those of established lines such as the 403 (D-F) (Origen 
Therapeutics, Inc.1450 Rollins Road, Burlingame, California 94010, USA) and 
the 9N2 (G-I) (Acloque et al., 2001) lines. (Scale bar = 80µm). 
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Figure 2.1: Morphology of cES cells 
 
 
 
 47 
 
2.5. Reporter constructs for Sox2 enhancers 
 
Kindly gifted from Professor Hisato Kondoh of the Graduate School of Frontier 
Biosciences, Osaka University Japan, the Plasmids which were used to 
identify active enhancer regions of Sox2 were based on the plasmid tk-EGFP 
reporter vectors used in the original study (Uchikawa et al., 2003). These 
plasmids were constructed by insertion of the Herpes simplex virus thymidine 
kinase promoter in the polylinker HindIII site of pCAT3-basic vector (Promega), 
and replacing the CAT gene with the EGFP gene (Clontech). Twenty-six 
plasmids each contains one conserved regulatory element upstream and 
downstream of the chick Sox2 locus (Uchikawa et al., 2003) were tested (See 
Figure 2.2, Table 2).  
 
The regulatory sequence was inserted in the polylinker SmaI site of ptkEGFP. 
The chromosomal locations and other characteristics of these sequences are 
shown in (Table 2). As a control for electroporation, pCAB, a plasmid 
containing the chicken β-actin promoter driving GFP, was used. A ‘negative 
control’ promoter was also used to identify the baseline activity of the minimal 
promoter following transfection. This plasmid contained the minimal promoter 
thymidine kinase (tk) and the EGFP gene with no enhancer sequence inserted 
upstream of the tk promoter.  
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Figure 2.2: Plasmids used for testing the activity of Sox2 enhancers in 
cES cells: Twenty-six plasmids each contains one conserved regulatory 
element located upstream and downstream of the chick Sox2 locus (Table 2) 
(Uchikawa et al., 2003) were tested. These plasmids were constructed by 
insertion the conserved regulatory element upstream of the Herpes simplex 
virus thymidine kinase promoter. This complex would identify the enhancers of 
these regulatory sequences by driving the expression of the reporter gene 
EGFP (Clontech) if the regulatory sequence had an activity in transfected 
cells.  
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Figure 2.2: Plasmids used for testing the activity of Sox2 enhancers in 
cES cells 
 
 
EGFP 
Sox2 enhancer 
tk pro 
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Table 2: Conserved sequences of Sox2 across amniote species 
 
Block Bp* Assigned 
Enhancer 
Specificity of 
 Enhancer 
Earliest 
Stage¶ of 
Activity 
Length* in 
Chicken 
genome 
Position in 
Chicken 
genome¥ 
Homology 
in Human 
(%) 
Homology 
in Mouse 
(%) 
1 438       496 -16175 77 68 
2 639 N3 DC/MC/Early 
lens 
8 585 -15133 t 89 71 
3 509       487 -11102 62 Absent 
4 891       875 -10068 71 68 
5 334 NOP-1 Nasal/Otic 
placodes 
11 323 -8811 83 81 
6 308       145 -7803 75 68 
7 179       143 -5310 75 71 
8 550 N2 TC, MC, DC  5* 534 -3012 90 87 
9 147       147 -1198 84 81 
11 103      103 3427 63 61 
12 295       287 4314 83 83 
13 395 NOP-2 Nasal/Otic 
placodes 
11 374 5105 85 77 
13.5 201       138  Absent Absent 
14 395 N-5 RC; r-2, r-4 12 366 8151 75 72 
15 205       188 9872 71 71 
16 358       344 10445 87 86 
17 324 N-1 Anterior PS 5* 298 12825 83 72 
18 415 SC-1 SC   413 13666 81 65 
19 394       362 15041 84 80 
20 208       127 16389 74 61 
21 312       292 16988 61 Absent 
22 169 SC-2     171 18450 70 69 
22.5 201       161  62 Absent 
23 171       158 20551 67 (55) 
24 556 N4 Head 
ectoderm/SC 
10 480 22339 78 73 
25 700 NC-1 Dorsal root 
ganglia 
17 676 29610 85 Absent 
 
* Sequence block length in the Plasmid (base pairs) 
¶ Stages are according to (Hamburger and Hamilton, 1951) table. 
¥Position is in relation to Sox2 genomic locus. Negative sites refer to sequences positioned upstream of Sox2 locus.  
PS: primitive streak, SC: Spinal cord,  
RC: Rhombencephalon, TC: Telencephalon, MC: Mesencepalon, DC: Diencephalon 
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2.6. Transfection with LIPOFECTAMINE™2000 
 
Based on methods that were developed by (Felgner et al., 1987; Felgner et 
al., 1989), Lipotransfection with LipofectamineTM2000 was used to transfect 
DNA into cES cells in 24-well plates. For other well sizes, a scaling table 
(Table 3) was used. Transfection method was optimized in relation to 
transfection efficiency and cell survival using different Lipid:DNA ratios. Figure 
2.3 and Figure 2.4 show the outcome of experiments used to optimize the 
lipotransfection procedure. Following optimization, all transfection experiments 
reported in this thesis used a Lipofectamine TM 2000:DNA ratio of 3:1 (µg/µl). 
 
The transfection process would start by seeding the feeder layer cells at a 
density of 104 cells/cm2 and incubated at 37ºC overnight. The following day, 
cES cells were plated at a density of 105 cells/cm2 and incubated in BRL 
conditioned medium for 18-24 hours. For each transfection, two 1.5 ml tubes 
were prepared: in the first 1 µg DNA was diluted in 99 µl of Opti-MEM® I 
reduced serum. In the second 3 µl LIPOFECTAMINE™2000 was diluted with 
97 µl of Opti-MEM® I reduced serum and incubated at room temperature for 5 
minutes. The solutions of the two tubes are then combined and incubated at 
room temperature for 20 minutes. The combined solution (total of 200 µl) is 
then added to each well, mixed gently and incubated for 6 hours at 37ºC. After 
6 hours, one ml of fresh ESA medium was added and incubation continued 
overnight. On the first day following transfection (18-24 hours following 
transfection) the transfected cES cells were examined under fluorescence 
illumination to check for GFP expression. Cells’ culture medium was changed 
and cells incubated for another day. On the second day post transfection (36-
48 hours following transfection), the medium was changed and cells were 
checked again for GFP expression, counted, recorded in the spreadsheet, and 
the photographs were taken before cells were fixed in 40% paraformaldehyde 
(PFA) in phosphate buffered solution (BPS). 
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Table 3: Scaling of transfection volumes with Lipofectamine TM 2000 for 
different sizes of wells 
 
Shared Reagents DNA transfection Culture 
Dish 
Surface 
area 
(cm2) 
(per 
well) 
Volume 
of 
plating 
medium 
Volume 
of 
dilution 
medium 
DNA (µg) 
 
LipofectamineT
M 2000 (µg) 
96 well 0.3 cm2 100 µl 2 x 25 µl 0.25 µg 0.75 µl 
24 well 2 cm2 500 µl 2 x 50 µl 1 µg 3 µl 
12 well 4 cm2 1 ml 2 x 100 µl 2 µg 6 µl 
6 well 10 cm2 2 ml 2 x 250 µl 4 µg 12 µl 
60 mm 20 cm2 5 ml 2 x 0.5 ml 8 µg 24 µl 
10cm 60 cm2 15 ml 2 x 1.5 ml 24 µg 72 µl 
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Figure 2.3: Optimizing lipotransfection of cES Cells: The sequential 
LipofectamineTM2000:DNA ratios 3:1, 4:1, 5:1 were tried. Transfection 
efficiency, assessed by the number of green fluorescent cells 36 hours 
following transfection, was as high with Lipid:DNA ratio 3:1 (A,D,G and Figure 
2.4) was as high as that observed following transfection with 4:1 (B,E,H) and 
5:1 (C,F,I) ratios. Cells’ survival, assessed by number of cells in CM2 on the 
following day following EGFP assay (60-72 hours following transfection) as an 
indicator of cells’ ability to continue proliferation following transfection, was 
related to the amount of LipofectamineTM2000 used. Decreased cell counts 
(likely due to LipofectamineTM2000 toxicity) were observed when higher 
Lipid:DNA ratios were used (compare J with K,L) (Scale bar = 80µm). 
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Figure 2.3: Optimizing lipotransfection of cES Cells 
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Figure 2.4: Lipotransfection of cES Cells - Efficiency vs Survival: The 
sequential LipofectamineTM2000:DNA ratios 3:1, 4:1, 5:1 were tried. 
Transfection efficiency, assessed by the number of green fluorescent cells 36 
hours following transfection, was as high with Lipid:DNA ratio 3:1 as that 
observed following transfection with 4:1 and 5:1 ratios. Cells’ survival, 
assessed by number of cells in CM2 on the following day following EGFP 
assay (60-72 hours following transfection) as an indicator of cells’ ability to 
continue proliferation following transfection, was related to the amount of 
LipofectamineTM2000 used. Decreased cell counts (likely due to 
LipofectamineTM2000 toxicity) were observed when higher Lipid:DNA ratios 
were used (See also Figure 2.3  above) . 
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Figure 2.4: Lipotransfection of cES Cells - Efficiency vs Survival 
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2.7. Cell counting and basic statistical analysis 
methods 
 
To determine the activity of the reporter constructs, cell survival and mRNA 
expression, related cells (eg green fluorescent cells following transfection) 
were counted using a 20x objective in an Olympus Vanox-T microscope with 
epi-fluorescence optics for GFP. The total number of cells in the same field 
was counted using phase contrast optics. Tissue culture wells of each 
experiment were blindly selected. For each well, six separate fields spanning 
the horizontal equator of the well were recorded, transferred to a spreadsheet 
before performing statistical analysis to report the characteristics of these 
relevant cells (eg mean ± standard deviation of green fluorescent cells) 
 
Analysis of variance (ANOVA) was used to assess statistical significance in 
the number of GFP-expressing cells between different plasmids with 
Bonferroni adjusted post-hoc tests’ analysis to make individual comparisons 
between two individual set of scores. A P value of 0.05 was accepted as 
statistically significant. All statistical analyses were performed using SPSS for 
Windows, Release 14 (SPSS Inc.).  
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2.8. In situ hybridization (ISH) of chick embryonic 
stem cells (cESCs). 
2.8.1. Transcription of DIG-riboprobe 
 
Vectors were cut with the appropriate restriction enzyme for 4-5 hours or 
overnight and verified by agarose gel electrophoresis using 1/20th of the initial 
reaction volume. The DNA was then extracted with Phenol:Chloroform 
followed by Na-Acetate/Ethanol precipitation after which the DNA was 
dissolved at about 1mg/ml. The DIG-riboprobe was then transcribed with the 
appropriate enzyme (T3, T7 or SP6) at 37 oC for 2 hours (for SP6 transcription 
2-3 times the amount of DNA template was used and transcription done at 
40oC). The remaining DNA template was then digested with DNase I for 30 
minutes and the DIG-riboprobes checked by agarose gel electrophoresis. The 
probe was precipitated with Lithium Chloride and ethanol, washed in 70% 
ethanol and re-dissolved in water at about 1 mg/ml. This was then further 
diluted about 5-10x (to 100-200 µg/ml) in hybridization buffer for storage at -20 
oC. 
2.8.2. Preparation of cESCs for ISH 
Cells were fixed in freshly made 4% paraformaldehyde (PFA) in BPS for 15 
minutes at 4 oC. PFA is then replaced with absolute methanol and cells stored 
in this for up to 1 week at -20 oC. If cells needed to be kept longer before in 
situ, they were taken through the first day ISH procedure (below) until just 
before adding the probe and then kept at -20 oC until needed.  
 
On the first day, cells were rehydrated through 75%, 50% and 25% methanol 
in Calcium Magnisium Free (CMF) PBS containing 0.1% Tween-20 (PTW) at 
room temperature and washed twice with PTW at room temperature for 5 min. 
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Cells were then post-fixed for 30 minutes at room temperature in 4% 
paraformaldehyde in PTW containing 0.1% glutaraldehyde and rinsed twice 
with PTW at room temperature. . Cells were then washed twice with 
hybridization solution (See Table 4 for composition) twice for 1 hour each at 
room temperature before incubation in a Techne Hybridiser HB-1D oven at 
68oC for 3 hours. The hybridization mix was then replaced with the appropriate 
pre-warmed probe in hybridization mix and left to incubate in the oven at 68oC 
overnight. 
Table 4: Composition of the hybridization solution 
 
Component (stock conc.) Final conc. volume to add 
Formamide 50% 25 ml 
SSC (20x, pH 5.3 adjusted 
with citric acid) 
1.3x SSC 3.25 ml 
EDTA (0.5M, pH 8.0) 5mM 0.5 ml 
Yeast RNA (20mg/ml) 50µg/ml 125 µl 
Tween-20 0.002 100 µl 
CHAPS (10%) 0.005 2.5 ml 
Heparin (50 mg/ml) 100µg/ml 100 µl 
H2O  ~18.4 ml 
Total:  50 ml 
 
On the second day, the cells were rinsed once and washed twice (30 min 
each) in pre-warmed hybridization solution, then a further 20 min in 1:1 
hybridization solution: TBST (composition?) at 68oC. Followed by 3 1-hour 
washes in TBST at room temperature. Cells were then incubated in blocking 
buffer (TBST containing 5% heat inactivated sheep serum and 1 mg/ml BSA) 
for 1 hour before incubation overnight at 4 oC in a 1:5,000 dilution of alkaline-
phosphatase-conjugated anti-DIG antibody (manufacturer?) in blocking buffer. 
 
On the third day, cells were rinsed three times and then washed three times 
(one hour each) in TBST. After two 10 min washes in NTMT (composition?), 
alkaline phosphatase activity was revealed by incubation at room temperature 
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in NTMT containing 4.5 µl nitro-blue Tetrazolium (NBT; 75mg/ml in 70% DMF) 
and 3.5 µl bromo-chloro-indole phosphate (BCIP; 50mg/ml in 100% DMF) per 
1.5 ml. Staining required between 15 min and occasionally up to 48 hours at 
room temperature. The staining reaction was then stopped by washing twice 
for 10 min in TBST. Cells characteristics were recorded photographed and 
fixed as in the procedure described above. 
2.9. Immunohistochemistry and β-gal staining of 
chick embryonic stem cells (cESCs). 
2.9.1. β-Gal staining 
 
Chick embryonic stem cells were fixed with freshly made 4% formaldehyde in 
PBS for 15 minutes. They were then rinsed with PBS twice before incubation 
in X-Gal solution (9 ml water, 500µl PBS x20, 200 µI K4[Fe(CN)6], 200 µI 
K3[Fe(CN)6], 20 µI MgCl2 and 100-200 µI freshly thawed X-Gal at 37°C for 
between 1 hour and overnight, as required. The reaction was stopped with 
PBS or PBT.  
2.9.2. Immunohistochemistry and staining with DAPI 
To reveal GFP from reporter plasmid transfections, or assess molecular cell 
characteristics of cES cells the following immunological methods were used. 
Chick ESCs were fixed in 4% paraformaldehyde in PBS for 15 minutes at 4°C, 
washed in PBS three times for 5 minutes and blocked in 1% Triton-X100 and 
1% BSA in PBS for 30 minutes at room temperature. The primary antibody 
(diluted in blocking buffer) was then added overnight at 4°C. The cells were 
then washed with PBS (3 x 5 minutes), and then incubated overnight at 4°C in 
the secondary antibody (diluted in blocking buffer). The cells were then 
washed in PBS (3 x 5 minutes) and mounted with a glass coverslips in 
(Citiflour) mounting medium.  
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In some experiments, following the washes and before mounting, cells nuclei 
were stained with DAPI (4’,6-Diamidine-2’-phenylindole dihydrochloride) 
(Roche Diagnostics , Germany) (Russel et al., 1975) [Diluted in distilled water 
to constitute 5mg/ml stock solution and in methanol to a final concentration of 
1µg/ml to constitute working solution] using the following steps: First, cells 
were rinsed once with DAPI-methanol working solution. Secondly, cells were 
incubated in DAPI-methanol at 37ºC. for 15 minutes. Thirdly, DAPI-methanol 
solution was removed. Finally, the cells were rinsed once with absolute 
methanol, air dried, then mounted in coverslips of stored in fix as described 
above. 
2.9.3. Antibodies 
Primary antibodies for 3A10 neurofilament (post-mitotic neuron specific 
marker) (Furley et al., 1990; Storey et al., 1992) and the glial cell marker EAP3 
(McCabe et al., 1992; Napeir et al., 1999; Yuan et al., 1997) were bought from 
the Developmental Studies Hybridoma Bank (Iowa University, USA). TUJ-I: A 
neuron specific (Ferreira and Caceres, 1992; Maurer et al., 2007; Miura and 
Kameda, 2001; Scott et al., 1990) beta III tubulin antibody was bought from 
Abcam, (UK). Secondary antibodies (Alexa Flour 488 (green),  
 
Table 5 provide the details of the main antibodies used in this project and 
their characteristics. 
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Table 5: Antibodies Description 
 
Antibody Antigen 
 
Source Cells/ 
Flourophore 
detection 
colour 
Species Host Type 
Primary 3A10 
(Neuro- 
filament) 
DHB§ 
USA 
Postmitotic 
neurons 
Chick Mouse IgG1 
Primary EAP3 
(Transitin) 
DHB USA Glial cells Chick Mouse IgG 
Primary TUJ-1  
(Class III β 
tubulin) 
Abcam 
UK 
Neuron specific  Chick Mouse IgG2a 
Primary GFP Invitrogen 
UK 
GFP Rabbit Rabbit IgG 
Secondary Mouse IgG 
(H+L) 
Invitrogen 
UK 
Alexa Flour 
(Red) 
Mouse Donkey αIgG 
Secondary Mouse IgG 
(H+L) 
Invitrogen 
UK 
Alexa Flour 488 
(Green) 
Mouse Donkey αIgG 
Secondary Rabbit IgG 
(H+L) 
Sigma UK Alexa Flour 
(Red) 
Rabbit Donkey αIgG 
 
§ DHB: Developmental Studies Hybridoma Bank (Iowa University, USA) 
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Chapter 3. Identification of enhancers 
responsible for Sox2 expression 
in chick ES cells 
3.1. Introduction 
 
As discussed in Chapter 1 Sox2 is a definitive neural marker (Albazerchi and 
Stern, 2007; Linker et al., 2009; Papanayotou et al., 2008; Stern, 2006) which 
plays a key role in regulating the factors implied in specification of early neural 
tissue and subsequent development of the central nervous system of the 
vertebrates’ embryos (Catena et al., 2004; Cavallaro et al., 2008; Ellis et al., 
2004; Episkopou, 2005).  
 
Cross-species comparisons of non-coding regions associated with the Sox2 
locus identified 25 highly conserved blocks of non-coding sequences which 
were then tested using reporter assays (Uchikawa et al., 2003). Although the 
expression of Sox2 mRNA in the developing chick embryo from stage 4 
(Hamburger and Hamilton, 1951) seems uniform throughout the neural plate 
and consequent developing CNS, the above study revealed that this pattern of 
expression results from the sum of the activities of five distinct enhancers (N1 
through N5) which are found widely scattered upstream and downstream of 
the sole exon of Sox2. Reporter assays revealed that these five enhancers not 
only have distinct spatial expression but are also activated at different times: 
N-2 is activated first, followed by N-1 and finally N-3, N-4 and N-5. Five other 
enhancers controls its expression in other locations of the developing embryo 
leaving fifteen conserved sequences with no identified activity (Kamachi et al., 
2009; Kondoh and Uchikawa, 2008; Uchikawa et al., 2003) 
 
Work on regulation of Sox2 in early embryo CNS development in other animal 
models showed that as it is in the chick developing embryo, the expression of 
Sox2 mRNA during other vertebrates’ embryo neural development as well as 
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in mouse embryonic and neural stem cells is regulated by these very 
enhancers. (Catena et al., 2004; Inoue et al., 2007; Kamachi et al., 2009; 
Zappone et al., 2000) 
 
The experiments in this Chapter were designed to test whether any of the 25 
enhancer elements described by H. Kondoh’s group as being responsible for 
regulating Sox2 expression in the embryo can also drive expression in 
proliferating chick embryonic stem cells. 
 
3.2. Methods 
 
Three cell lines of chick embryonic stem cells were maintained and expanded 
in 48 well plates as described in Chapter 2. Mitomycin C treated STO feeder 
cells seeded at confluence concentration were used as a negative control. For 
each cell line two parallel independent experiments were performed. In each 
experiment plasmids containing one of 25 Sox2 conserved regulatory 
elements [Total of 26 plasmids containing all 25 conserved sequences (except 
sequence sumber 10) with two conserved sequences (No. 13, 22) having two 
corresponding plasmids each] reporter plasmids as well as two other plasmids 
(pCAβ-gfp and tk-EGFP) were used. The pCAβ-GFP plasmid controls for 
transfection efficiency (positive control) and the tk-EGFP plasmid controls for 
the baseline activity of the minimal promoter thymidine kinase when it is not 
coupled to an identified regulatory element (negative control). Cells were 
transfected with plasmid DNA with LipofectamineTM 2000 as described in 
Chapter 2. 
 
The activity of the regulatory element being tested was assessed by 
percentage of green fluorescent cells to the total of cells observed 36 hours 
following transfection. Six consecutive 20x objective fields were scored for 
each well (experiment). Fluorescent cells were counted after 36 hours of 
transfection. Cell counts were logged into a spread sheet and the percentages 
of green fluorescent cells over total number of cells in the field were 
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calculated. For each experiment descriptive statistics were calculated using 
SPSS programme and comparison of plasmid activity was made by non-
parametric Kruskal-Wallis test. A P value of less than 0.05 was accepted as 
statistically significant. Planned Mann-Whitney follow up tests with Bonferroni 
correction were used to compare the difference of plasmid activity between the 
three cESC cell lines and the feeder layer cells. 
3.3. Results 
3.3.1. Activity of Sox2 conserved sequence blocks in 
cES cell lines and STO feeder cells  
 
A detailed record of activity of different plasmids used in this experiment in the 
four cell lines transfected is presented in Table 6. Figure 3.1 represent a 
graphical presentation of a summary of the same data. As the cell counts’ 
distribution was not normal, figures presented include both mean and median 
percentage of green fluorescent cells with non-parametric tests used for 
comparisons. 
 
1] The 9N2 cell line 
 
Median transfection efficiency was 61.4% with a range of 38.9 – 73.3%. There 
was a minimal baseline activity of the thymidine kinase minimal promoter (tk) 
with 0 – 0.3% of cells scored as positive for the reporter gene GFP. 
Nevertheless, the median percentage of green fluorescent cells was 0%. Out 
of the 26 plasmids containing the putative regulatory elements of the sox2 
locus only 3 displayed activity with a median green fluorescent cell counts that 
was greater than the median of the negative control. These three plasmids are 
C8, C11, C17 with median percentage green cell counts of 19.6%, 0.2% and 
2% respectively. Fluorescent were cells observed in wells transfected with 
plasmid C1, C22.5 and C23 with mean percentage of 0.08, m0.25% and 
0.36% respectively. The median percentage of green cells detected following 
transfection by these two cells was 0% for both of them. No green fluorescent 
cells were detected following transfection with the other plasmids.
 66 
 
Table 6: The activity of the identified enhancers of Sox2 gene in chick 
embryonic stem cells 
 
9N2 cell line 403 cell line 30 cell line STO feeder cells LINE / 
Plasmid Mean SD Median Mean SD Median Mean SD Median Mean SD Median 
PCAB 60.1* 9.7 61.4 57.0 7.7 56.6 33.0 10.2 33.5 40.0 8.9 40.2 
Tk.GFP 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 
C1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 
C2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 
C3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
C4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
C5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
C6 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.0 
C7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
C8§ 20.0 4.7 19.6 13.4 5.7 11.5 14.0 7.9 13.5 0.0 0.0 0.0 
C9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 
C11§ 0.5 0.6 0.2 0.5 0.6 0.3 0.1 0.2 0.0 0.0 0.0 0.0 
C12 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 
C13 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.1 0.2 0.0 
C13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 
C14 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 
C15 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
C16 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 
C17§ 1.5 0.8 2.0 1.4 1.6 1.0 0.1 0.2 0.0 0.0 0.1 0.0 
C18 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 
C19 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 
C20 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
C21 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 
C22 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 
C22.5 0.3 0.4 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.2 0.3 0.1 
C23 0.4 0.5 0.0 0.3 0.5 0.0 0.3 0.6 0.0 0.1 0.3 0.0 
C24 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
C25 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 
 
* Average percentage of fluorescent cells is represented by the mean, SD and 
median percentages of fluorescent cells in 6 counts of 20x objective field in 
two independent experiments (wells).  
§ Plasmids with conserved sequence which has significant variance of activity 
in cES cells and STO feeder cells (Kruskal-Wallis test; significance accepted 
at p value <0.05) 
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Figure 3.1: Functional analysis of Sox2 regulatory blocks in proliferating 
chick embryonic stem cells. Transfection with Lipofectamine® in three cESC 
lines 9N2 (A1 – D2); 403 (E1 – H2); 30 (I1 – L2) and STO feeder layer cells 
(M1 – P2). The first column shows the results of transfection of the pCAB-gfp 
plasmid. Green fluorescent cells were detected in all 4 cell lines (A2, E2, I2, 
M2). The second column shows the baseline activity of the minimal promoter 
thymidine kinase (tk) with no additional regulatory element.This result matched 
those of the regulatory elements with no activity in these cell lines under the 
experimental conditions.  The third column shows the results of transfection of 
plasmid C8-tk-EGFP, corresponding to the N2 enhancer. Green cells were 
observed primarily in the cESC lines (C2, G2, K2) compared to the control 
feeder cells (O2). The last column shows the results following transfection with 
the C11-tk-EGFP plasmid. Green cells were observed mainly in the 9N2 & 403 
cESC lines (D2 & H2) where the regulatory element C11 seems to be more 
active. In the cESC primary line 30 C11 was found to have less activity (L2). 
Note that C11 also has some activity in feeder layer of STO cells (P2); to a 
lesser extent other constructs also show including the minimal tk promoter 
alone (panels N2 and O2, each containing a single, very faintly fluorescent cell 
[arrows]). Only The N2 enhancer is exclusively active in all cESC lines 
compared to the feeder layer cells (C2, G2, K2, O2) (Scale bar = 80µm). 
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Figure 3.1: Functional analysis of Sox2 regulatory blocks in proliferating 
chick embryonic stem cells. 
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2] The 403 cell line 
 
Median transfection efficiency was 56.6% with a range of 40.9 – 69%. There 
was a minimal baseline activity of the thymidine kinase minumal promoter (tk) 
with 0 – 0.3% of cells scored as positive for the reporter gene GFP. 
Nevertheless, the median percentage of green fluorescent cells was 0%. Out 
of the 26 plasmids containing the putative regulatory elements of the sox2 
locus the same 3 plasmids found to have activity above the negative control 
plasmid in the 9N2 cell line were found to have similar activity in the 403 cell 
line too. Median green fluorescent cell counts percentages for these three 
plasmids (C8, C11, C17) was 11.5%, 0.25% and 1% respectively. Green 
fluorescent protein positive cells were also observed in wells transfected with 
plasmid C1, C3, C5, C6, C9, C12, C13, C14, C15, C18, C20, C22.5, C23 and 
C25. Only C22.5 and C23 had a mean percentage greater than 0.1% (0.24% 
and 0.3% respectively). The median percentage of green cells detected 
following transfection by these two plasmids (as well as the rest of the 26 
vectors) was 0%.  
 
3] The 30 cell line 
 
Transfection efficiency was the lowest with median of 33.5 %, range of 11 - 
48%. There was no baseline activity detected of the thymidine kinase minimal 
promoter (tk). Green fluorescent cells were detected following transfection of 
plasmids C2, C4, C6, C8, C11, C12, C13, C13.5, C14, C15, C17, C18, C21, 
C22, C22.5, C23, C24, C25. The C8 plasmid had the greatest activity with a 
median percentage of green cells of 13.5. The activity of the remaining 
regulatory elements was minimal with a green cells percentage median of 0%.  
 
4] The STO cell line 
 
Median transfection efficiency was 47.9 %, range 23.9 - 52%. There was 
minimal baseline activity detected of the thymidine kinase minimal promoter 
(tk) with mean percentage green fluorescent cells of 0.08%. Green fluorescent 
cells were detected in small numbers following the transfection of plasmids 
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C1, C9, C12, C13, C13.5, C16, C17, C19, C21, C22.5, C23. All such activity 
was The C22.5, C23 plasmids had the greatest activity with a mean 
percentage of green cells of 0.17% and 0.13% respectively. The activity of all 
the remaining regulatory elements was minimal with a green cells percentage 
median of 0%.  
 
3.3.2. Statistical analysis of activity of Sox2 conserved 
sequence blocks  
 
Using the Kruskal-Wallis test, the median percentage of green fluorescent 
cells was found to be significantly different following the transfection of the 
following plasmids: PCAB-GFP, C8, C11 and C17; H(3) = 30.2, 31.2, 12.8, 26 
respectively (p<0.05). Figure 3.2 shows the average (mean) percentage of 
green fluorescent cells detected following transfection of all 28 plasmids in the 
3 cESC lines as well as in the STO feeder layer cells. The largest proportion of 
green cells was detected following transfection of pCAB-gfp. Transfection 
efficiency varied between experiments and cell lines with a mean total 
efficiency of 47.5 ± 14.5%. Transfection efficiency of the 9N2, 403, 30 cESC 
lines were 60 ± 9.7%, 57 ± 7.7% and 33 ± 10.2 % respectively. The 
transfection efficiency of the STO feeder cells was 40 ± 8.9 %. In contrast, a 
baseline activity of the minimal promoter reporter (tk-EGFP) plasmid was 
detected in the 4 cell lines. The mean green fluorescent cells detected 
following tk-efgp transfection in all wells was 0.04 ± 0.12 %. 
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Figure 3.2: Differences in activity of different plasmids in different cESC 
lines (9N2, 403, 30) and STO feeder cells 
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Four different patterns emerged from comparison of the proportion of 
fluorescent cells following the transfection of the 28 plasmids. First, plasmids 
with activity in 4 cell lines. Apart from pCAB-gfp (positive control), only C22.5 
and C23 had such a pattern, with a few green cells detected in some but not 
all wells. Overall, the mean proportion of green fluorescent cells detected 
following the transfection of these two plasmids was 0.2 ± 0.3 % for C22.5 and 
0.3 ± 0.5 % for C23. 
 
The second type of pattern observed corresponds to plasmids producing no 
activity in any cell line. In addition to the negative control plasmid tk-EGFP, 
most of the 26 constructs yielded this result. Plasmids with sequence blocks 
C1, C2, C4, C5, C7, C9, C12, C13.5, C15, C16, C18, C19 and C24 had no 
detectable activity. In addition, plasmids with sequence blocks C3, C6, C13, 
C14, C20, C21, C22 and C25 can be included in this group as the number of 
green fluorescent cells detected in some of the wells was similar to that of the 
negative control tk-EGFP. 
 
The third pattern consists of plasmids with activity in some cESC lines. 
Plasmids containing C11 and C17 comprise this group. Green fluorescent 
cells were detected with these two plasmids predominantly in the 9N2 and 403 
cESC lines. The former plasmid (C11) produced 0.5 ± 0.6 %, 0.5 ± 0.6, 0.05 ± 
0.2 and 0.0 ± 0.0 % respectively in cell lines 9N2, 403, 30, STO lines, and the 
latter (C17) yielded 1.5 ± 0.8, 1.4 ± 1.6, 0.08 ± 0.2 and 0.01 ± 0.05 % 
respectively in the same lines. 
 
The fourth pattern was yielded by plasmids showing activity in all cESC lines 
but not in STO feeder cells. Only C8, corresponding to the N2 enhancer, was 
in this group. The average proportions of green fluorescent cells detected in 
the 9N2, 403, 30 cESC lines were 20 ± 4.7, 13.4 ± 5.7 and 14 ± 7.9 % 
respectively. No activity was detected in the STO feeder layer cells. 
 
Mann-Whitney tests were used to follow up these findings to compare the 
percentage of green fluorescent cells between the STO feeder layer and each 
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of the three cESC lines (3 tests per plasmid). A Bonferroni correction was 
applied and so statistical significance is only accepted at p value of less than 
0.0167.  
 
No significant difference was seen in the percentage of green cells between 
the STO feeder cells and each of the three cESCs following transfection of the 
negative control (tk-gfp), C11, C22.5, C23 and C25. The median percentage of 
green fluorescent cells in the cESC line 9N2 was significantly greater than that 
of the STO feeder cells following transfection of plasmids pCAβ-GFP, C8, 
C17. The median percentage of green fluorescent cells observed in the 403 
cESC line was greater than that of the STO feeder layer following transfection 
of pCAβ-GFP and C8 plasmids. Finally, only following transfection of C8 was a 
significant increase observed in the percentage of green fluorescent cells 
detected in the cESC line 30 compared to the feeder layer. Thus, although 
transfection efficiency was greater in cESC lines 9N2 and 403 than in feeder 
cells, only plasmid C8 (N2 enhancer) had significantly more activity in all cESC 
lines as compared to that observed in the STO feeder cells. Figure 
3.3summarizes these findings. 
 74 
 
Figure 3.3: Differences in the activity of plasmids between STO and cESC 
lines. Box-plot graphs comparing the percentages of green fluorescent cells 
detected following the transfection of the main active plasmids found. A. 
pCAβ-gfp (transfection efficiency/positive control) activity varied between cell 
lines and both 9N2, 403 cESC lines displayed greater transfection efficiency 
than the feeder cells (STO). A significant difference in activity of a conserved 
Sox2 sequence (enhancer) between cES cell lines and STO feeder cells is 
marked by an asterisk (as a Bonferroni correction was applied, statistical 
significance is only accepted at p value<0.0167). B. Tk-egfp (negative control) 
showed minimal activity in all cell lines and no difference between feeder and 
cESC lines. C. C8 (N2 enhancer) was the only plasmid with activity exclusively 
in cESC lines. D. Although C11 has activity in 9N2 and 403 cESC lines, this 
activity was not significantly higher than its activity in the STO cells. E. C17 
(N1 enhancer) has activity in 9N2 and 403 cESC lines similar to that of C11. 
The activity of the N1 enhancer, although low, was significantly greater in the 
9N2 cESC line than in the STO feeder cells. F, G. The C22.5 and C23 
elements produce some activity in all cESC lines as well as in the feeder cells 
but no significant difference is detected between them. H. C25 produces very 
low activity, seen in only two of 48 fields scored. This is representative of what 
is seen with the remaining plasmids have no activity in either cESC cell lines 
or in the STO feeder cells. 
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Figure 3.3: Differences in the activity of plasmids between STO and cESC 
lines. 
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3.4. Discussion 
 
By comparing the chick Sox2 locus with that of the mouse and the human, 
Hisato Kondoh’s group identified twenty-five highly conserved sequence 
blocks (Uchikawa et al., 2003). Electroporation of reporters comprising each of 
these enhancers along with a minimal promoter (tk) into developing chick 
embryos was then used to test the domains of the embryo in which each of 
these elements can drive transcription. Expression of these elements was first 
detected at around stage 5 (Hamburger and Hamilton, 1951). Within the 
developing nervous system five enhancers account for the expression pattern 
of Sox2 mRNA during the first 2 days of development.  
 
N2 is activated earliest and in the largest domain, corresponding to the entire 
anterior neural plate down to the level of the node at stage 5 (future forebrain, 
midbrain and anterior hindbrain). Very shortly afterwards, N1 is activated in 
small triangular regions of paranodal epiblast. This position corresponds to the 
‘‘stem zone’’ defined by Kate Storey’s group (Delfino-Machín et al., 2005). This 
region contains precursor cells that contribute to both the posterior neural 
plate (from the posterior hindbrain down to the caudal tip of the spinal cord) 
and part of the paraxial mesoderm (Delfino-Machín et al., 2005). 
 
Until very recently it was thought that Sox2 is not expressed in chick embryos 
before about stage 5 (Rex et al., 1994; Rex et al., 1997b; Uchikawa et al., 
2003; Uwanogho et al., 1995) and its expression in chick ES cells was also 
unknown. However, Sox2 is expressed in both mouse ES cells (Avilion et al., 
2003; Masui et al., 2007) and in the epiblast of the early mouse embryo (Wood 
and Episkopou, 1999; Zappone et al., 2000). The activity of regulatory 
elements of Sox2 in mouse embryonic stem cells has been studied by 
(Zappone et al., 2000) who found activity of a 5’ region of about 400 base 
pairs when linked to a 3.3 kb region upstream of the Sox2 reading frame which 
they consider to contain a Sox2 minimal promoter (Catena et al., 2004; 
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Zappone et al., 2000). Sequence comparisons reveal that the former 400 base 
pair region corresponds to the chick N2 enhancer of (Uchikawa et al., 2003). 
The work presented in this chapter suggests that out of the 25 elements 
identified by Kondoh, the N2 enhancer is the one that most strongly drives 
expression of a GFP reporter in chick embryonic stem cells. The activity of this 
enhancer is also specific to cES cells as no significant activity was seen in the 
STO feeder cells. 
 
Our work utilized the minimal promoter thymidine kinase rather than the 
putative Sox2 minimal promoter identified by Catena et al. (2004). The very 
low baseline activity of the tk promoter enables the activity of the N2 enhancer 
to be determined more easily and reveals that N2 is sufficient to drive 
expression in cES cells independently from the 3.3 kb segment upstream of 
the Sox2 open reading frame (Catena et al., 2004).  
 
It is also worth noting that only 20% of cells appear to display activity of the N2 
enhancer. Sox2 mRNA expression can be detected in up to 90% of cESCs 
(see below Chapter 5). Limited transfection efficiency is probably not sufficient 
to account for this difference because even in the 9N2 cell line which displays 
the highest levels of N2 activity, transfection efficiency (measured by activity of 
the ubiquitously-expressed pCAβ-EGFP reporter) is 60%. Ideally, curves with 
increasing amount of DNA should have been constructed to maximise the 
transfection efficiency for each of these plasmids, and this should have been 
coupled with co-transfection of a ubiquitously expressed reporter of 
transfection efficiency producing fluorescence of a different colour (eg. DS-
Red or RFP). Differences in the efficiency of the different promoters, DNA 
concentration (including those due to differences in plasmid length) and other 
factors could contribute to account for the differences. In addition, it is possible 
that elements in addition to N2 contribute to expression in cES cells and could 
account for the difference between the 20% observed and the expected 54% 
(90% adjusted for transfection efficiency). These additional elements could be 
among those identified by (Uchikawa et al., 2003) and also tested here, if they 
only work in combination, but they could include additional elements not 
identified from Kondoh’s study. Further work, starting from exploring 
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combinations of the elements tested here, is needed to answer these 
questions. 
 
In their study of enhancers driving Sox2 expression in mouse ES cells, Catena 
et al (2004) showed that the mouse enhancer sequence equivalent to the N2 
region contains multiple POU binding sites. Using gel shift assays and 
chromatin immunoprecipitation they showed that Oct1 and Oct4 can bind to 
these domains both in vitro and vivo (Catena et al., 2004). The chick Oct3/4 
homologue was originally thought not to exist  (Soodeen-Karamath and 
Gibbins, 2001). However more recently PouV has been identified as the chick 
homologue of mammalian Oct3/4, its expression demonstrated in chick 
embryonic stem cells along with a role in regulating pluripotency of these cells 
(Lavial et al., 2007) . PouV may therefore be an important factor in regulating 
Sox2 expression in chick ES cells by binding to the N2 enhancer. 
 
The low levels of activity shown by some of the other elements in this study, 
and especially C11 and C17 (N1 enhancer), might be explained by a low level 
of spontaneous differentiation. This is consistent given the low number of cells 
that show these activities as compared to the C8 region (N2 enhancer). It is 
also possible that C11 and/or C17 are among additional elements required to 
account for the full expression of Sox2 in cES cells as discussed above, and 
these may only work in conjunction with N2 and/or other elements. 
 
The other regions found to have some activity in ES cells also have activity in 
STO cells: C22.5 and C23. The expression in STO cells (which are not known 
to express Sox2 mRNA) suggests that this activity is likely to be an artefact, 
perhaps due to sequestering ubiquitous or other transcription factors 
expressed in these cells. 
 
The differences in activity of the N2 region and mRNA expression in cES cells 
could also indicate the existence of silencers within N2 or in other DNA 
regions. To identify these regions quite different experiments need to be 
designed, including nested deletions and/or other mutations of the reporter 
constructs. A final possibility is that the lower expression seen with the N2 
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reporter constructs as compared with Sox2 mRNA in cES cells might partly be 
due to competition of the transfected reporter for transcription factors that are 
already engaged in activating the endogenous Sox2 gene. It might be 
interesting to compare the levels of expression of Sox2 mRNA in cells 
transfected with a N2 reporter as compared with other sequences: if this 
competition is taking place one might find reduced Sox2 mRNA expression in 
N2-transfected cells. 
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Chapter 4. Methods for inducing neural 
differentiation in chick ES cells 
4.1. Introduction 
 
Since their initial isolation from mouse embryos (Evans and Kaufman, 
1981;Martin, 1981), embryonic stem (ES) cells have offered new tools to 
explore many aspects of the control of cell commitment and differentiation. 
Differentiated cell types belonging to descendants of all three germ layers of 
the embryo can be produced from mammalian ES cells. Examples from the 
mouse model include endodermal derivatives such as the yolk sac 
(Doetschman et al., 1985) or the pancreas (Ku et al., 2004); mesodermal 
tissues: primitive and definitive hematopoietic cells (Nakano et al., 1996) , 
cardiomyocytes (Doetschman et al., 1985), striated (Rohwedel et al., 1994) 
and smooth (Yamashita et al., 2000) muscle fibers , adipocytes (Dani et al., 
1997), chondrocytes (Kramer et al., 2000) and osteoblasts (Buttery et al., 
2001) and ectodermal derivatives such as skin (Bagutti et al., 1996), neuronal 
(Bain et al., 1995; Strubing et al., 1995) and glial lineages (Brüstle et al., 1999; 
Fraichard et al., 1995; Liu et al., 2000). 
 
Although ES cells are capable of differentiating into potentially all somatic cell 
types, the study of the events of cell commitment and of differentiation into 
each of these fates requires reproducible methods to direct them to specific 
fates. For in vitro induced neural differentiation of ES cells, three different 
strategies have been established with variable efficiency and reproducibility: 
embryoid body (EB) formation-based method (Doetschman et al., 1985), 
stromal cells-mediated method (Kawazaki et al., 2000) and methods based on 
differentiation of ES cells as a monolayer in defined medium (Tropepe et al., 
2001; Ying et al., 2003; Ying and Smith, 2003).  
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To date, reproducible protocols have only been described for mouse ES cells 
although pioneering studies by Pain et al. (1996) demonstrated the ability of 
chicken ES cells to produce neurons in vitro. In this paper, cESCs were found 
to have the ability to differentiate into neuron like cells following Embryoid 
Body formation as well as with spontaneous differentiation. These cells were 
positive to the neuronal marker N-CAM. No other reports of cES induced 
neural differentiation exist as their multi-germ layer differentiation  potential is 
explored in vivo (Petitte et al., 2004). None of the cES cells induced 
differentiation methods provide insights about the efficiency of in vitro induced 
neural differentiation (Acloque et al., 2001; Lavial and Pain, 2010; Pain et al., 
1996; Petitte et al., 2004). 
 
In addition to the lack of reproducible methods for generating neural cells from 
chick ES cells, no study has yet directly compared these different strategies 
described above in any system model using the same outcome measure (See 
Table 7). This chapter compares the effectiveness of two of the three main 
methods to induce neural differentiation of mouse ES cells for the chick ES 
cell system. 
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Table 7: Reports on in vitro induced neural differentiation of embryonic 
stem cells in mouse and chick 
 
 
Reference Model In vitro method Outcome measure Efficiency 
Bain et al 
1995  
Mouse Embryoid Bodies (EB) 
[-/+ RA 5x10-7M] 14 
days 
Morphology + RT-
PCR 
(Brn3,GFAP,TH) 
38% neuron like cells on 
day 7 
Fraichard et 
al 1995  
Mouse EB 2+/7-/D&P 20 days 
[-/+RA 10-7M] 
Morphology + RT-
PCR 
(Nestin, GFAP, O4, 
MAP2) 
MAP2, 5 ;NF200 
10% neuron like day 6 
Wichterle et 
al 2002 
Mouse EB 3+/5- days  
[-/+RA 10-7 – 2x10-6 M] 
Co-Culture on Pa6 for 
6 days 
Section of EB and 
IHC 
(Sox1, Otx2, Hoxc6, 
NeuN., En1,Tuj1) 
40-60% Sox1+ day 3 
 
50-70%NeuN+ day 7 
Ying et al 
2003 
Mouse Monolayer N2B27 
medium 
[ +/- Shh/FGF4] up to 
14 days 
ES Cell reporter Cell 
line, 
FACS 
60% Sox1+ day 5 
60%Tau-gfp + day 7 
Pain et al 
1996 
Chick Embryoid Bodies  
[-/+ RA 5x10-7M] 
15 days 
Morphology + IHC (N-
CAM) 
Not reported 
This study Chick EB  
[+/- RA10-6M] 15 days 
 
Monolayer with N2B27 
[+/-RA 5x10-7-5x10-6M] 
21 days 
Morphology, IHC 
(3A10 neurofilament, 
Transitin, TUJ-1) 
28% 3A10+ cells day 21  
 
5% Transitin+ cells day21 
30+% 3A10+ day 21 
10%+ TUJ-1+ day 21 
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4.2. Methods 
 
4.2.1. Proliferating cES cells expansion  
BRL conditioned medium supplemented with supplemented with: 1 mM 
sodium pyruvate (Gibco, UK), 1% non-essential amino acids (Gibco,UK), 1% 
Vitamins (Gibco, UK), 1 mM of each nucleotide (adenosine, guanidine, 
cytosine, uridine, thymidine; Chemicon, USA), 0.16 mM b-mercaptoethanol 
(Chemicon, USA), 100 U/ml penicillin and 100 mg/ml streptomycin (Gibco, UK) 
(ESA medium) was used to grow and expand embryonic stem cells in their 
proliferating multipotent state as discussed in Chapter 2 above. 
4.2.2. Development of embryoid bodies in vitro 
ES Cells were dissociated, washed in Ca/Mg free PBS and plated in low-
adhesion culture dishes (Nunc) at 5x106 cells/ml ESA medium without LIF. 
Fresh medium was added every 2 days for 4 days. ESA medium was 
supplemented with 10-6M of all trans-RETINOIC ACID (Product No R2625, 
Sigma UK) for another 4 days. After 8 days, floating masses of cells were 
collected, washed carefully, dissociated in trypsin (0.25% trypsin/EDTA in PBS 
with 1:5 ratio) and plated onto gelatine coated tissue culture wells or glass 
coverslips to allow them to attach, spread and differentiate.  
4.2.3. In Vitro Differentiation on a monolayer 
Proliferating cES cells were dissociated and plated onto gelatine coated 
dishes without feeder cells at a density of 5x104/cm2 in DMEM or N2B27 
medium (Brewer et al., 1993;Ying et al., 2003;Ying and Smith, 2003) 
supplemented with 0.5% Fetal Bovine Serum. In experiments that had a 2-day 
pulse of Retinoic acid (see below), all trans-Retinoic acid (Sigma R2625) was 
added to the medium in the first 2 days in either low (5x10-7M) or high 
concentration (5x10-6M). The medium was renewed every 2 days for 20 days. 
On the 21st day post-treatment, cells were fixed and stained as described 
below. As a control and for assessment of the incidence of spontaneous 
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differentiation, cES cells were kept in ESA – complete BRL conditioned 
medium for the duration of the differentiation protocol.  
 
4.3. Results 
 
4.3.1. Embryoid body-based protocol 
 
The purpose of ultra-non adhesive dishes is to prevent cell attachment, which 
favours the formation of Embryoid Bodies (EB) (Doetschman et al., 1985). 
Within 18 – 24 hours of plating, cell aggregates appeared in suspended lumps 
resembling embryoid bodies of mammalian ES cells (Bain et al., 1995). By day 
2 these have become large and spherical (See Figure 4.1). On day 5 the 
medium was changed; half the wells received medium supplemented with 
106Mall-trans RA.  
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Figure 4.1: Embryoid Bodies (EB) – like aggregates of cES cells: cES Cells 
aggregates resembling mammalian Embryoid Bodies appear at the end of the 
first day of passaging multipotent cells in ultra low adhesive tissue culture 
plate and withdrawing proliferation-maintaining growth factors (Scale bar = 
50µm) 
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Figure 4.1: Embryoid Bodies (EB) – like aggregates of cES cells 
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On day 9 the aggregates were dissociated with Trypsin EDTA solution and 
gentle pipetting and plated on regular tissue culture dishes and cultured for a 
further 4 days in a RA-free medium. Cells were seen to attach to the plates 
quickly and cells started to spread out from the partly-dissociated EBs, . After 
4 days, cells started acquire different morphologies, quite different to that of 
the starting multipotent cES cells (Figure 4.2). Instead of the spindle-like 
morphology of cES cells, there were many cells with needle-like shapes (a 
small body with multiple thin processes), astrocyte-like shapes (star-like, 
irregular and flat cells with short pointed processes) and larger flat cells which 
cover almost the entire surface of the culture dish.  
 
To test for neuronal and glial differentiation cells were fixed and stained for 
markers of differentiating neurons (3A10; neurofilament) (Furley et al., 1990; 
Storey et al., 1992) and immature neural progenitors/glial cells (EAP3; 
transitin) (McCabe et al., 1992; Yuan et al., 1997), which is considered to be 
the chick equivalent of nestin (Napeir et al., 1999). In the RA treated group 
11.3% ± 4.1 (S.D.) of cells stained with 3A10. In the control group 2.1 ± 0.7% 
of cells expressed 3A10. 15.9 ± 1.4% of cells in the RA group were staining for 
transitin, compared with 4.1 ± 3.3% in the control group. These differences 
between the RA and control were statistically significant (p<0.05). (See Table 
8 for summary). 
 
Figure 4.3 (also quantification in Figure 4.4) shows examples of cES cells 
expressing 3A10 and EAP3. Neither antibody produced staining of 
proliferating cES cells (see below) and there was also no staining when the 
primary antibody was ommitted (control not shown). These findings confirm 
earlier findings that cES cells can be directed to neuronal fates by an embryoid 
body-mediated method (Pain et al., 1996).  
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Table 8: Differentiation of cES cells with an EB based protocol. 
 
    4-/4+/D&P 4    4-/4-/D&P 4  
Marker Exp Positive 
cells 
total cells 
counted 
%  positive 
cells 
total 
cells 
counted 
% 
3A10 1 64 413 15.5%  4 325 1.2% 
  2 37 506 7.3%  11 416 2.6% 
  3 48 433 11.1%  7 298 2.3% 
    Mean 11.3%   Mean 2.1% 
    SD 4.1%   SD 0.7% 
Transitin 1 123 723 17.0%  12 512 2.3% 
  2 88 614 14.3%  28 354 7.9% 
  3 91 554 16.4%  9 442 2.0% 
    Mean 15.9%   Mean 4.1% 
    SD 1.4%   SD 3.3% 
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Figure 4.2: Changes in cell morphology following induced differentiation 
of cES cells: A1,2: Chick ES cells have a spindle-like morphology with large 
prominent nucleus and relatively little cytoplasm. Following induced neural 
differentiation of cES cells either with EB based protocol or as a monolayer, 
striking morphological changes occur (B-D). The main emerging 
morphological patters of differentiated cES cells are needle-like (B1,2) (a small 
body with multiple thin processes), astrocyte-like (C1,2) (star-like, irregular and 
flat cells with short pointed processes) and larger flat cells which cover almost 
the entire surface of the culture dish (D1,2). (Scale bar in A1 = 50µm). 
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Figure 4.2: Changes in cell morphology following induced differentiation 
of cES cells 
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Figure 4.3: Neural marker expression in cES cells from embryoid bodies: 
A-D: Neuronal (3A10) and glial (EAP3: Transitin) markers were detected 
following EB formation. More cells expressing these neural markers was noted 
with addition of Retinoic Acid (A,B) compared with the control (C,D) (See also 
Figure 4.4) (Scale bar in A1 = 50µm). 
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Figure 4.3: Neural marker expression in cES cells from embryoid bodies 
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Figure 4.4: Quantification of cES cell differentiation from embryoid bodi: 
Neuronal (3A10) and glial (EAP3: Transitin) markers were detected following 
EB-like aggregates formation. More cells expressing these neural markers 
was noted with addition of Retinoic Acid compared with the control (See also 
Figure 4.3). 
 
 94 
 
Figure 4.4: Quantification of cES cell differentiation from embryoid 
bodies 
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4.3.2. Monolayer culture in defined medium 
 
Neural differentiation of ES cells via embryoid bodies (Bain et al., 1995; Wiles 
and Johansson, 1999), culture in suspension (Tropepe et al., 2001) or co-
culture with stromal cell lines (Kawasaki et al., 2000) have all been criticised 
as being difficult to control as well as for producing very heterogeneous 
cultures  (Smith, 2001). The use of defined media would eliminate the 
variability of serum containing medium, improving reproducibility. By 
developing a reporter cell line in which green fluorescent protein was inserted 
into the Sox1 locus, Ying et al at (2003) showed that monolayers of mouse ES 
cells could be efficiently directed to a neural fate including neuronal and glial 
cell cell types by modifying the medium in which these cells are cultured (Ying 
et al., 2003). These authors introduced a medium known as N2B27 which was 
found to be particularly efficient at supporting neural differentiation (Brewer et 
al., 1993; Ying et al., 2003; Ying and Smith, 2003). 
 
This method (Ying et al., 2003; Ying and Smith, 2003) was tested for cES. As 
described for mouse ES cells, in vitro differentiation of cES cells is started by 
removing factors that maintain their proliferative state (feeder cells, 
conditioned medium) and exposing them to a two day ‘priming’ period when 
cells are exposed to RA followed by growth in N2B27 medium for 18 days 
(Ying et al., 2003). RA was used at two concentrations: 5x10-7 M and 5x10-6 M 
(represented in figures and tables as +ra and +RA respectively). To assess 
the effect of N2B27 on efficiency of induced neural differentiation, control 
DMEM was used in both the initial priming and subsequent 18 days 
differentiation periods. On the 21st day cells were fixed and stained for EAP3 
and 3A10 markers. 
 
Chick ES cells do not express 3A10 or EAP3 when cultured in standard cES 
medium (where they continue to proliferate) (Figure 4.5: A1-4).  On the other 
hand, many cells with neuronal morphology and 3A10 and EAP3 expression 
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are seen following the 20 days treatment with N2B27, both with and without 
RA (Figure 4.5 and Figure 4.6). 
 
Figure 4.7 and Table 9 present a summary of the results of different 
combinations of the DMEM, N2B27 media with or without RA. The lowest level 
of differentiation for both markers was seen when cells were primed and 
cultured in plain DMEM medium. This medium failed to support cell 
proliferation as compared cells grown using both feeder layers and ESA 
(Complete BRL conditioned medium). Only a small number of cells survived 
the former culture conditions (Figure 4.5; compare [A1-4] and [B1-4]). The 
highest amount of neuronal differentiation was seen when cells were grown in 
N2B27 following priming with the higher concentration of RA. This produced 
cultures containing many neurite processes forming complex networks (Figure 
4.6 I1-4). Other conditions produced neuronal-like cells with variable efficiency 
(Figure 4.5 and Figure 4.6 : C1-4 through H1-4; Figure 4.7 and Table 9). 
 
Neurites seemed to extend from areas of greater cell density (Figure 4.5: 
D1,D2; Figure 4.6: F1,F2; G1,G2 and I1,I2]. The complexity of neurite 
networks also varied between conditions. To evaluate the networks a 4 point 
score was devised. The presence of occasional neurites was scored (-), small 
neurites with an area within 100x100 µm were scored (+) (Figure 4.5: D1-
D2),neurites with an area greater than (+) but within 200x200 µm were scored 
as (++) (Figure 4.6: G1-G2 and H1-H2) and neurites occupying an area 
greater than 200x200µm were scored (+++). Only N2B27 medium following 
priming with the higher concentration of RA produced the highest score 
(Figure 4.6: J1-J2, Figure Figure 4.8 and Table 9). 
 
In contrast with the results of the Embryoid Body-based differentiation method, 
these cultures showed a lower proportion of EAP3 positive than 3A10 positive 
cells (Figure 4.5, Figure 4.6, Figure 4.7, Figure 4.8 and Table 9). The greatest 
number of transitin-expressing cells was seen when N2B27 was used both in 
priming (with lower dose of RA) and differentiation. These findings show that 
N2B27 medium supplemented with high RA concentration can efficiently direct 
cES cells to neuronal differentiation in vitro. 
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Figure 4.5: Neural marker expression by cES cells cultured in N2B27 
medium as an adherent monolayer (A) 
 
A1-A4: Chick ES cells do not express neuronal (3A10) or glial (EAP3) markers 
when cultured for 3 weeks in standard cES medium [A2 & A4 respectively] 
(where they continue to proliferate). B1-E4: Chick ES cells start spontaneous 
differentiation on monolayer culture following withdrawal of cES cells 
prolifration maintaining BRL conditioned medium (BRL – ESA) wherebye a few 
numbers of cells expressing the neuronal marker 3A10 (but not the glial 
marker EAP3 (A4-E4)) appear after 20 days of culture in DMEM with low 
(5x10-7 M) (C2) or high (5x10-6 M) (D2) concentration of retinoic acid (RA). No 
cells expressing the neuronal or the glial markers were identified after 3 weeks 
of monolayer culture in DMEM alone (B2, B4 respectively). In contrast, 
growing the cells in the N2B27 medium for 18 days following an initial 2 days 
‘priming’ period in DMEM yield many cells with neuronal morphology that 
express the post mitotic neuronal marker 3A10 (E2) (Scale bar = 100µm). 
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Figure 4.5: Neural marker expression by cES cells cultured in N2B27 
medium as an adherent monolayer (A) 
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Figure 4.6: Neural marker expression by cES cells cultured in N2B27 
medium as an adherent monolayer (B) 
 
F1-G4: Chick ES differentiation into neurons in monolayer culture medium is 
more efficient when they are treated with RA during the ‘priming’ period. Cells 
expressing the neuronal marker 3A10 appear in more number when RA 
concentration used increases (Compare F2: low RA concentration (5x10-7 M) 
to G2: higher RA concentration (5x10-6 M). A more efficient differentiation of 
cES cells into cells expressing neuronal and/or glial markers is seen when the 
N2B27 medium was used in the ‘priming’ period at the beginning of the 
monolayer culture neuronal differentiation 21 days protocol (Compare I2 and 
J2 with F2 and G2). The highest level of differentiation for both markers was 
seen when cells were primed and cultured in the N2B27 defined medium with 
high concentration of RA used during the priming period (J2 and J4). (Scale 
bar = 100µm) 
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Figure 4.6: Neural marker expression by cES cells cultured in N2B27 
medium as an adherent monolayer (B) 
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Figure 4.7: Various alterations of monolayer based protocol induced 
neural differentiation of cES cells. 
 
Figure 4.7 summarizes the results of different protocols used to induce in vitro 
neuronal an or glial differentiation of cES cells. DMEM or N2B27 medium with 
or without RA were used in the 2 days priming period. This was followed by 18 
days of cell culture as a monolayer in DMEM or N2B27 medium. The lowest 
level of differentiation for both markers was seen when cells were primed and 
cultured in plain DMEM medium. In contrast, the highest level of induced 
neuronal differentiation was seen when cells were primed and cultured in the 
N2B27 defined medium with high concentration of RA used during the priming 
period.  
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Figure 4.7: Various alterations of monolayer based protocol induced 
neural differentiation of cES cells. 
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Table 9: Induced neuronal differentiation of cES cells in defined media . 
 
Exp.l Protocol 
sequence 
RA 3A10+ cells 
(Mean%±SD) 
EAP3+ cells 
(Mean%±SD) 
Neurite 
formation 
(per cm2) 
Mean ± SD 
Neurite 
score 
1 (DMEM) + 
DMEM 
 0.4 ± 0.6 0.5 ± 0.1 0.0 ± 0.0 - 
2 (DMEM + ra) + 
DMEM 
5x10-7M 1.6 ± 0.1 1.4 ± 1.9 0.0 ± 0.0 - 
3 (DMEM + RA) 
+ DMEM 
5x10-6M 0.9 ± 0.1 0.3 ± 0.3 0.0 ± 0.0 - 
4 (DMEM) + 
N2B27 
 11.2 ± 3.5 1.8 ± 2.5 2.5 ± 0.7 + 
5 (DMEM + ra) + 
N2B27 
5x10-7M 15.6 ± 3.2 1.2 ± 0.9 5.5 ± 2.1 + 
6 (DMEM + RA) 
+ N2B27 
5x10-6M 15.9 ± 0.1 2.3 ± 0.5 7.0 ± 1.4 + 
7 (N2B27) + 
N2B27 
 13.8 ± 5.7 1.9 ± 1.4 5.0 ± 0.0 ++ 
8 (N2B27 + ra) + 
N2B27 
5x10-7M 26.0 ± 6.5 7.6 ± 0.4 8.8 ± 1.4 ++ 
9 (N2B27 + RA) 
+ N2B27 
5x10-6M 32.9 ± 8.3 3.3 ± 1.6 14.0 ± 1.4 +++ 
10 (BRL - ESA) + 
BRL - ESA 
 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 - 
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Figure 4.8: Neurite formation of cES cells following monolayer N2B27 
medium induced differentiation protocol. Neurite formation was possible 
following in vitro induced neural differentiation of cES cells using a different 
combination of DMEM and N2B27 medium for priming and monolayer culture. 
The N2B27 defined medium used for priming cES cells (with higher 
concentration of retinoic acid) and subsequently in culturing them for a total of 
21 days as a monolayer led to the most profuse neurite formation in 
comparison to other protocols.  
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Figure 4.8: Neurite formation of cES cells following monolayer N2B27 
medium induced differentiation protocol. 
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4.3.3. Expression of molecular markers in cES cells 
To assess the time course of neuronal differentiation, the expression profile of 
several markers was determined in cES cells during their in vitro neural 
differentiation using the [N2B27+RA] 2 days + N2B27 18 days protocol 
presented above. Cells were fixed and stained for neuronal markers (3A10 
and TUJ-I) at day 0, 10 and 20 to compare the trend of neuronal marker 
expression. Neither 3A10 nor TUJ-I was expressed in proliferating cES cells, 
(Figure 4.9: A,B and I, J). After the first half of the time course both antigens 
are expressed in about 13% and 6% of cells respectively (Table 10, Figure 4.9 
for 3A10: C,D,E and for TUJ-I: K,L,M and Figure 4.10). The proportion of 
expressing cells continues to increase to reach approximately 11% of 
differentiating cells in day 21 for TUJ-I and about a third of the cells for 3A10 
(Figure 4.9 for 3A10 F, G, H and for 3A10 N, O, P as well as Figure 4.10 and 
Table 10). This time course suggests neural differentiation of cES cells starts 
soon after the withdrawal of conditions supporting proliferation. 
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Figure 4.9: Expression of neuronal molecular markers in N2B27 induced 
cES cells: Following in vitro induced neural differentiation using the 
[N2B27+RA] 2 days + N2B27 18 days protocol (See above). cES Cells does 
not stain for neuronal markers (3A10 and TUJ-I) during its proliferating ‘stem’ 
state ( A,B and I, J). On the tenth day of the time course both antigens are 
expressed in about 13% and 6% of cells respectively (C, D, E (3A10) and 
K,L,M (TUJ-I)). The proportion of expressing cells continues to increase to 
reach approximately 11% of differentiating cells in day 21 for TUJ-I and about 
a third of the cells for 3A10 (F, G, H and N, O, P respectively). (Also see 
Figure 4.10 and Table 10) (Scale bar = 50µm). 
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Figure 4.9: Expression of neuronal molecular markers in N2B27 induced 
cES cells 
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Figure 4.10: Expression of neuronal molecular markers in N2B27 induced 
cES cells (Quantification): Following in vitro induced neural differentiation 
using the [N2B27+RA] 2 days + N2B27 18 days protocol (See above). cES 
Cells does not stain for neuronal markers (3A10 and TUJ-I) during its 
proliferating ‘stem’ state . On the tenth day of the time course both antigens 
are expressed in about 13% and 6% of cells respectively. The proportion of 
expressing cells continues to increase to reach approximately 11% of 
differentiating cells in day 21 for TUJ-I and about a third of the cells for 3A10 
(See also Table 10 ). 
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Figure 4.10: Expression of neuronal molecular markers in N2B27 induced 
cES cells (Quantification) 
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Table 10: Expression of neuronal (3A10 & TUJ-1) molecular markers in 
N2B27 induced cES cells. 
 
  EXP 1 
Day/State 3A10+ 
cells 
Total 
Counted 
% TUJ-I Total 
counted 
% 
Day 0 0 1125 0.0% 0 882 0.0% 
Day 10 72 612 11.8% 29 811 3.6% 
Day 21 354 912 38.8% 55 419 13.1% 
  EXP 2 
  3A10+ 
cells 
Total 
Counted 
% TUJ-I Total 
counted 
% 
Day 0 0 713 0.0% 0 1098 0.0% 
Day 10 119 801 14.9% 48 635 7.6% 
Day 21 143 528 27.1% 63 786 8.0% 
  Total 
Day 0 0 ± 0 % 0 ± 0 % 
Day 10 13.3 ±  2.2% 5.6 ± 2.8 % 
Day 21 32.9 ± 8.3 % 10.6 ± 3.6% 
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4.4. Discussion 
The results presented in this chapter show that two methods for inducing 
mouse ES cells to differentiate into neural fates are also effective in cES cells, 
but to different extents. A method based on an intermediate step of Embryoid 
Body (EB) production is somewhat efficient. However a much greater 
proportion of cells differentiates into cells expressing neural markers using a 
monolayer culture method where cells are primed with a high concentration of 
Retinoic Acid for 2 days in the presence of the defined neuronal culture 
medium N2B27 (Brewer et al., 1993; Ying et al., 2003; Ying and Smith, 2003) 
followed by further culture in N2B27. Thus, chick embryonic stem cells are 
comparable to their mouse counterparts in that they can be directed to neural 
differentiation with different protocols. The ability to direct cES cells to neural 
differentiation in defined medium overcomes the objections to studying neural 
commitment and differentiation in EB or stromal cell based assays (Bain et al., 
1995; Kawasaki et al., 2000). The monolayer/N2B27 method involves 
chemically defined media in the absence of serum, heterologous feeder cells 
or conditioned media. 
 
Here, neural identity was assessed by expression of 3 markers: the 
neurofliament-associated marker 3A10 (Furley et al., 1990; Storey et al., 1992; 
Yamada et al., 1991), the neuronal precursor and glial cell marker EAP3 
(McCabe et al., 1992; Napeir et al., 1999; Yuan et al., 1997) and the 
differentiating neuronal marker TUJ1 (Ferreira and Caceres, 1992;Maurer et 
al., 2007; Miura and Kameda, 2001; Scott et al., 1990) in a method based on 
monolayer cultures. Using 3A10 and TUJ1, the time course of acquisition of 
expression of these markers was assessed. Neuronal differentiation starts 
relatively early in the cultures, half way through the culture period. It is also 
worth noting that a smaller, but not insignificant amount of neural 
differentiation is seen in cultures kept in proliferation medium and/or when the 
priming and/or N2B27 steps are omitted. It will be important to determine 
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whether these conditions also support differentiation into other cell types to 
determine whether they particularly favour commitment into neural lineages. 
 
N2B27 medium alone produced about 15% neuronal differentiation and this 
seemed to increase by using the higher concentration of RA. The mode of 
action of retinoic acid in promoting differentiation (or specifically neural 
differentiation) has not been well defined and is thought to involve multiple 
signalling pathways (Bally-Cuif et al., 1995; Endo et al., 2009; Lu et al., 
2009;Ying et al., 2003) 
 
The inducing properties of the N2B27 medium may also be due to the 
summation of multiple signalling pathways. The most obvious component is 
Insulin-like Growth Factor (IGF). This and its related factor Insulin activate the 
MAP kinase cascade which is shared by FGF and have been reported to have 
neural inducing activity in several species (Fischer et al., 2009; Freund et al., 
2008; Pera et al., 2001). It is, therefore, conceivable that initial FGF (which is 
present in the proliferating-stimulating medium) followed by an FGF blocking 
signal (RA) and a low level of MAPK activation (IGF) is a cue for acquisition of 
neural fate [see also (Papanayotou et al., 2008; Sheng et al., 2003; Stern, 
2005a; Stern, 2006)]. 
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Chapter 5. Gene expression profile and 
activity of the N2 enhancer 
during induced neural 
differentiation of cES cells 
5.1. Introduction 
Chick ES cells are derived from apparently homogeneous epiblast cells of pre-
streak embryos (Pain et al., 1996). Chick ES cells can differentiate into 
descendants of the three germ layers (ectorderm, mesoderm and endoderm) 
both in vivo (Van de Lavoir et al., 2006b) and in vitro (Pain et al., 1996). 
Although cells from stage X blastoderms (from which chick ES cells are 
derived) can generate both somatic and germ line chimaeras when transferred 
to recipient embryos  (Petitte et al., 1990), their ability to contribute to the germ 
line is lost upon culture (Pain et al., 1996; Pain et al., 1999; Petitte et al., 2004; 
Van de Lavoir et al., 2006b). 
 
Undifferentiated, proliferating chick ES cells can be characterised by their 
expression of markers such as telomerase and alkaline phosphatase activity 
as well as antigens such as SSEA 1 & 3 and ECMA-7 (Pain et al., 1996;Petitte 
et al., 2004) and transcription of genes including ERNI/ENS1 (Acloque et al., 
2001), Oct4 and Nanog (Lavial et al., 2007). All of these markers are 
downregulated when cells are induced to differentiate (Acloque et al., 2001; 
Lavial et al., 2007). During the process of commitment to different cell types 
and the ensuing differentiation, the downregulation of these markers is 
accompanied by progressive acquisition of cell-type-specific markers. The 
differentiation of cES cells into mature cell types is a protracted process that 
takes several days (see Chapter 4), presumably reflecting that commitment to, 
and subsequent differentiation into, different cell types is a complex process 
comprising a hierarchy of distinct steps. A similar view has recently been 
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emerging from studies of the process of neural induction in the embryo 
(Papanayotou et al., 2008; Sheng et al., 2003; Stern, 2005b), although it is not 
yet clear whether neural induction in the embryo is an equivalent process to 
the acquisition of neural character by chick ES cells in vitro. One way to begin 
to address this question is to compare the time-course of changes in gene 
expression in the embryo and in ES cells that have been induced to 
differentiate. Here we study this during induced neural differentiation in chick 
ES cells (see also Chapter 4). 
 
The regulation of the Sox2 gene is particularly interesting. It is expressed in 
pre-primitive streak chick and mouse embryos as well as in ES cells in the 
proliferative state, is then transiently downregulated before becoming 
expressed again in the neural plate of the embryo and in maturing neural 
precursors in vitro (Avilion et al., 2003; Bani-Yaghoub et al., 2006; Bertocchini 
et al., 2010a; Masui et al., 2007).  In the embryo, Sox2 expression in the 
neural plate is initiated by activity of the N2 enhancer (Papanayotou et al., 
2008; Uchikawa et al., 2003). Surprisingly, the same enhancer appears to be 
responsible for Sox2 expression in proliferating ES cells (Catena et al., 2004); 
see also (Chapter 3). It is therefore of particular interest to determine the time 
course of changes in activity of the N2 enhancer, as a prerequisite to identify 
the key transcriptional regulators that control its activity during the proliferative 
phase, commitment and subsequent differentiation. This Chapter addresses 
this question for the activity of N2, some of its regulators uncovered from 
studies on early embryos, and other markers of the ES cell state and of early 
neural commitment and differentiation. 
 
In the embryo, with the help of fate maps one can study the gene expression 
profile hierarchy that precedes the development of a specific tissue/organ or a 
certain biological process by identifying the changes of gene expression of this 
tissue/organ from the earliest embryological ancestors following it through the 
stages of development until this tissue/organ and/or biological process has 
reached the developmental outcome specified.  
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To identify the gene expression hierarchy of a given set of genes associated 
with neural induction a similar approach can be employed following the 
epiblastic cells that are destined to become neural tissue in the adult. Table 11 
is a compilation of data and published literature of the expression profile of the 
10 markers studied in this section in medial epiblastic cells destined to 
become the anterior part of the adult central nervous system during stages X, 
XIII, 4+, 5+ and 6-9 of chick embryo development. State of expression of the 
specific genes are considered for future anterior CNS as per fate maps of 
forebrain development prepared by (Hatada and Stern, 1994) 
 
In this chapter, we report the patterns of expression in cES cells of 10 genes 
involved in regulation of the stem state and linage commitment in chick 
embryo. Gene expression profiles are studied first under conditions that 
maintain their proliferative state. Secondly, we study and report the changes in 
mRNA expression of these genes are described during the 10 days following 
induction of neural differentiation in vitro. Finally, changes in the activity of the 
N2 enhancer of Sox2 are followed during this 10-day time course, and this 
compared with the expression of Sox2 mRNA. 
 
5.2. Methods 
5.2.1. Gene expression in cES cells 
Ten genes were chosen that are normally expressed in the epiblast at the pre-
primitive streak stage and whose expression changes during early stages of 
neural plate development. This set includes markers for endoderm (Sox17) 
and mesendoderm (Brachyury), as well as markers of ES cells (PouV [Oct3/4], 
Nanog, and ERNI), and markers of different stages of neural plate 
development: Sox2, Sox3, Sox1, Otx2 and one regulator of Sox2 expression 
in the developing neural plate (BERT; (Papanayotou et al., 2008). Expression 
was studied by in situ hybridisation as described in Chapter 2. Table 12 lists 
the probes, source and references. 
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In order to standardise the probes’ signals plates of all days of the time course 
were prepared simultaneously. One the signal is developed and stopped in 
one well (corresponding to a specific day of the time course), then the 
revealing reaction of all wells corresponding to that gene in all other days 
would be stopped too. ISHn of whole embryos (at pre and post gastrulation 
stages) was used to calibrate the timing of signals. Staining reactions were 
stopped on the 6th day (See protocol in Chapter 2) if no signal developed. 
 
For each experiment, six random (non-overlapping) 20x objective fields were 
scored. A 5-point scoring system was used to describe gene expression:  
 
–: no expression detected expressed.  
+: the marker is expressed in small cohorts of cells (<50% of the cells scored).  
++: the marker is expressed more than half of the cells. 
+++: expression in almost all of the cells  
++++: as above, but also indicating particularly strong levels of expression. 
 
For Sox2 mRNA expressing cells and N2 activity experiments, cells were 
counted as described in Chapter 2. 
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Table 11: Hierarchy of expression of ten genes involved in regulation of 
the stem state and linage commitment in the developing chick embryo. 
 
 
 X XIII 4+ 5+ 6+ 
ERNI + + + + + 
Oct3/4 + + + + + 
Nanog + + + + + 
Sox1 - - - - + 
Sox2 -   + + + + 
Sox3 + + + + + 
Bert - - + + + 
Otx2 + + + + + 
Bra - - - - - 
Sox17 - - - - - 
 
During the first day of chick embryo development - from the stage of newly laid 
eggs [X: Eyal-Giladi & Kochav (1975)] up to 24 hours incubation [Stage 6+: 
Hamburger and Hamilton (1951; 1992)] – cells in the epiblast destined to form 
the anterior part of the central nervous system (forebrain) undergoes specific 
changes in their gene expression profile during early stages of neural 
differentiation. These changes are characterized by the upregulation neural 
markers (Sox1, Sox2, Bert) accompanied with upregulation of (ERNI, Oct3/4, 
Nanog, Sox3 and Otx2) and continuous downregulation of genes upregulated 
in the other two germ layers at the same developmental stage (Bra in the 
mesoderm and Sox17 in the endoderm). As a result, each cell of the embryo 
acquires a gene expressing profile that is specific to both its space and stage 
of development.  
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Table 12: Probes of gene markers used to study gene expression profile 
in differentiating cES cells 
 
Insert name Description Cut 
emzyme 
Transcribe 
enzyme 
Source Reference 
ERNI Wpst Subclose 
for ERNI for 
ISH 
KpnI T3 Cloned at 
C D Stern lab 
Streit et al.  2000 
cBra9 Chick 
Brachyury 
XbaI T3 Gift from  
J C Smith 
Smith et al. 1991 
BERT Chick BERT EcoRI T3 Cloned at  
C D Stern lab 
Papanayotou et 
al. 2008 
Ip06 Chick 
Oct3/4 
NcoI SP6 Gift from  
B Bain  
Lavial et al. 2007 
PFL Nanong Chick 
Nanog 
ApaI SP6 Gift from  
B Bain 
Lavial et al. 2007 
pBSXsox17α Chick 
Sox17 
SmaI T7 Gift from 
Woodland 
Hudson et al. 
1997 
cSox-3 Chick Sox3 PstI T7 Gift of  
R. Lovell-Badge  
& P. Scotting 
Uwanogho et al. 
1995 
cSox2 Chick Sox2 PstI, 
NcoI 
T7 Gift of  
R. Lovell-Badge  
& P. Scotting 
Uwanogho et al. 
1995 
cSox1 Chick Sox1 XhoI T7 Gift of  
H Kondoh 
Kamachi et al 
1998  
cOtx2 Chick Otx2 XhoI T3 Gift of L.  
Bally-Cuif &  
E Boncinelli 
Bally-Guif et al 
1995 
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5.2.2. Induction of differentiation of cESCs 
Chick ES cells were maintained in culture as described in Chapter 2. Neural 
differentiation was triggered by culture as a monolayer in N2B27 medium. 
However, cells cultured in N2B27+RA medium did not survive lipofectamine 
transfection (not shown). It turned out to be necessary to use N2B27 in the 
presence of 1% fetal calf serum. 
5.2.3. Plasmid design 
As described earlier in this thesis, pioneering work in Hisato Kondoh’s 
laboratory led to the discovery of many distinct enhancers regulating different 
aspects of Sox2 expression (Uchikawa et al., 2003). Subsequent analysis of 
the N2 enhancer by the same group identified two essential sub-regions 
sufficient to drive the expression of a reporter in the area where Sox2 mRNA is 
normally expressed in the prospective neural plate just after gastrulation 
(Iwafuchi et al., 2008). These sub-regions are 176-bp and 73-bp long, the 
latter being contained within the former. They are highly conserved between 
chick, mouse and man. 
 
To analyse the N2 enhancer and its two core sub-regions, as well as to align 
the corresponding sequences from different species, the Mulan software 
package (Loots and Ovcharenko, 2007) was used. The results of this analysis 
are presented in Figure 5.1 and Appendix 1. 
 
Five reporters comprising: the full N2 region, the 176bp and 73bp core 
regions, and N2 lacking each of these regions, driving expression of EGFP 
were kindly provided by Professor Kondoh’s laboratory. Figure 5.1. Line 9N2 
of chick ES cells was transfected with Lipofectamine2000TM. EGFP was 
visualised by fluorescence microscopy in unfixed, living cultures. 
Immunohistochemistry, ISH, cell counting and photography were done as 
described in Chapter 2. 
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Figure 5.1: Further dissection of the sequence of the N2 enhancer 
reveals 2 essential highly conserved core subregions: Subsequent 
analysis of the N2 enhancer by the same group identified two essential sub-
regions sufficient to drive the expression of a reporter in the area where Sox2 
mRNA is normally expressed in the prospective neural plate just after 
gastrulation. These sub-regions are 176-bp and 73-bp long, the latter being 
contained within the former. They are highly conserved between chick, mouse 
and man (See Appendix 1). 
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Figure 5.1: Further dissection of the sequence of the N2 enhancer 
reveals 2 essential highly conserved core subregions 
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5.2.4. Statistical analysis 
A parametric ANOVA test was used to evaluate the activity of the reporter 
constructs during neural differentiation. A paired Student’s t test was used for 
comparisons between pairs for plasmid activity. Pearson’s r test was used to 
correlate between Sox2 mRNA expression and the activity of N2 during the 
time-course of induced neural differentiation. Figures are presented as mean ± 
SD and activity refers to the average percentage of green fluorescent cells in 
non-overlapping 20x objective fields in 2 independent experiments, performed 
on different days using different batches of cells (See Chapter 2). 
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5.3. Results 
5.3.1. Patterns of gene expression during induced 
neural differentiation 
5.3.1.1. Gene expression profile of proliferating 9N2 cES cells 
 
Proliferating 9N2 cells express Sox2, PouV [Oct3/4] and Nanog (Figure 5.2 A-
F). Most cells express of Sox2 mRNA [scored as +++] but the intensity of 
staining is variable (Figure 5.2 A, B). Expression of PouV mRNA is also 
generalised and strong [+++] (Figure 5.2 C, D). Nanog expression is more 
variable [+/++] and the intensity of staining varies between groups of cells 
within the same culture (Figure 5.2 E, F). ERNI is very strongly expressed in 
almost all cells [++++] (Figure 5.2 G, H). Sox3 mRNA is expressed by a sub-
set of cES cells [+/++] (Figure 5.2 M, N). Otx2 is expressed in a small subset 
of cells [+] (Figure 5.2 O, P). Proliferating cES cells do not express BERT 
(Figure 5.2, I, J), Sox1 (Figure 5.2 K, L), Sox17 (Figure 5.2 Q, R) or Brachyury 
(Figure 5.2 S, T) [- in all cases] (Scale bar = 100µm).  
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Figure 5.2: Gene expression profile of the 9N2 cES cell line in the 
proliferative 'stem' state: Proliferating 9N2 cells express Sox2, PouV 
[Oct3/4] and Nanog (A-F). Most cells express of Sox2 mRNA [scored as +++] 
but the intensity of staining is variable (A, B). Expression of PouV mRNA is 
also generalised and strong [+++] (C, D). Nanog expression is more variable 
[+/++] and the intensity of staining varies between groups of cells within the 
same culture (E, F). ERNI is very strongly expressed in almost all cells [++++] 
(G, H). Sox3 mRNA is expressed by a sub-set of cES cells [+/++] (M, N). Otx2 
is expressed in a small subset of cells [+] (O, P). Proliferating cES cells do not 
express BERT (I, J), Sox1 (K, L), Sox17 (Q, R) or Brachyury (S, T) [- in all 
cases].  
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Figure 5.2: Gene expression profile of the 9N2 cES cell line in the 
proliferative 'stem' state 
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5.3.1.2. Gene expression during induced neural differentiation 
 
For these experiments, neural differentiation of cES cells was induced by 
culture in N2B27 medium without retinoic acid in the presence of 1% fetal calf 
serum (see above). Changes of gene expression were followed over a 10-day 
time course following induced neural differentiation. The results are presented 
in Table 13, Figure 5.3, Figure 5.4, Figure 5.5 and Figure 5.6. 
 
Following application of N2B27 medium, cES cells downregulate expression of 
ES cell markers Sox2, PouV, Nanog and ERNI (Figure 5.3, Figure 5.4). In the 
first 3 days following induced neural differentiation, Sox2 expression weakens 
(Table 13, Figure 5.3: A-F, M-P). By day 4 Sox2 is weakly expressed in the 
centre of islands of particularly confluent cells (Table 13, Figure 5.3: Q, R). 
Between days 5-7 expression starts to involve more cells, peaking at day 7 
(Table 13, Figure 5.3: G-J, S-T). From day 8 to day 10 Sox2 is progressively 
downregulated (Table 13, Figure 5.3: K, L, U, V). By day 10 there is a marked 
change of cell morphology, cultures now containing many needle-like cells 
(Figure 5.3: K, W) and Sox2 expression being restricted to small clumps of 
cells (Table 13, Figure 5.3: K, L, W, X).  
 
The expression of PouV, Nanog and ERNI also decreases in the first half of 
the time-course (Table 13, Figure 5.4: G-J, M-P, S-V). In the second half of the 
time course expression of these markers continues to decrease (unlike the 
upregulation seen for Sox2 from day 4-5) (Table 13, Figure 5.3, Figure 5.4: K, 
L, Q, R, W, X). 
 
The expression of pre-neural and early neural plate markers (Otx2, Sox3, 
Sox1 and BERT) also undergoes dynamic changes. Otx2 and Sox3 did not 
change during the time course: clumps of cells expressing these markers were 
found at all time points (Table 13, Figure 5.5: G-L, M-R). Although the cell 
clumps expressing these two markers looked more prominent in some fields 
towards the very end of the time course (Figure 5.5: K, L, Q, R) these 
increases were not uniform and did not affect the score 
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BERT and Sox1 were both upregulated during the time course (Table 5.2, 
Figure 5.5: A-F, S-X). Sox1 expression first appeared at day 5 (Table 13, 
Figure 5.5: A-D) and remained, albeit weakly, until the end of the time course 
(Table 13, Figure 5.5: E, F). BERT started to be expressed between days 4-5 
(Table 13, Figure 5.5: S-V). However, in contrast with the persistently weak 
expression of Sox1, BERT expression becomes stronger over days 6-7 before 
weakening towards the end of the time course (Table 13, Figure 5.6: I-P). 
 
Brachyury expression first appears weakly on day 5 (Table 13, Figure 5.6: A-
D). This expression quickly increases over the next 2 days and becomes 
expressed in almost half the cells by day 7 (Table 13, Figure 5.6: E, F). 
Expression then remains high until the end of the time course (Table 13, 
Figure 5.6: E, F). In contrast no expression of the endodermal marker Sox17 
was observed during the entire time course (Table 13, Figure 5.6: Q-V). 
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Table 13: Expression profiles of 10 marker genes during induced neural 
differentiation of cES cells 
 
 D0 D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 
ERNI ++++ +++ +++ ++ ++ ++ + + + + + 
Oct3/4 +++ ++ ++ + + + + + + + + 
Nanog +++ ++ ++ ++ + + + - - - - 
Sox1 - - - - - + + + + +/- +/- 
Sox2 +++ - - -/+ + ++ +++ +++ ++ + - 
Sox3 +/++ + + + + + + + + + + 
Bert - - - - + + ++ ++ + +/- +/- 
Otx2 + + + + + + + + + + + 
Bra - - - - - -/+ + ++ ++ ++ ++ 
Sox17 - - - - - - - - - - - 
 
Gene expression profile of cES cells changes during the first 10 days of a 21-
day in vitro induced neural differentiation protocol by monolayer culture in the 
N2B27 medium. During this period, cES cells undergo downregulations of the 
genes associated with the pluripotent proliferative state (ERNI, Oct3/4 and 
Nanog). Sox2 has a bi-phasic expression profile with early downregulation in 
the first three days followed by upregulation (day 3-7) then a late 
downregulation (day 8-10). The late neural marker Sox1 and Bert are 
upregulated in the second half of the time course. The mesodermal marker 
Bra is also upregulating in the second half of the time course suggesting that 
the N2B27 medium does not bias cells to induced neural differentiation 
exclusively. Sox3 and Otx2 are upregulated without detected changes of 
expression during the time course and Sox17, which is expressed in the 
endoderm during early stages of chick embryo development, continues to be 
downregulated in cES cells during the 10-days time course (Compare with 
table 5.1 for expression of these genes in ectodermal cells destined to form 
the forebrain during early stages of chick embryo development)  
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Figure 5.3: Sox2 expression during induced neural differentiation of cES 
cells. 
 
By in-situ hybridization (ISH) - [Each time point is represented by two pictures, 
the top e.g. Day 0 – A is taken with phase contrast microscopy setting, and the 
bottom e.g. Day 0 – B is taken with bright field microscopy setting for better 
elaboration of the ISH signal color], Sox2 mRNA has a bi-phasic expression 
profile with early downregulation in the first three days followed by 
upregulation (day 3-7) then a late downregulation (day 8-10). The number of 
cells expressing Sox2 mRNA in cESCs during induced neural differentiation 
was noted to change with initial decrease in the first three days of a 10-days 
time course (A-F, M-P); then an increase on the fourth day of the time course 
(Q-R) peaking on day 7 (I, J); then another decrease in the last third of the 
time course (Days 8 – 10: K-L, U-X) (Scale bar = 80µm). 
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Figure 5.3: Sox2 expression during induced neural differentiation of cES 
cells. 
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Figure 5.4: Changes of gene expressions profiles of cES cells 'stem' 
state markers during induced neural differentiation 
 
ISH of cES cells mRNA gene expression during the first 10 days of cES cells 
induced neural differentiation demonstrated here with the blue colour of the 
ISH mRNA probes at the start (base proliferative stage - Day 0), mid-point 
(Day 5) and last day (Day 5). In contrast with the bi-phasic expression profile 
of Sox2 mRNA, which is upregulated in the proliferative stage (A, B); at the 
midpoint (C, D) and downregulated on the last day (E, F), the mRNA 
expression of other proliferative ‘stem’ state marker genes Oct3/4, Nanog, 
ERNI is progressively downregulated during this time course (G-L, M-R and S-
X respectively) (Scale bar = 100µm). 
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Figure 5.4: Changes of gene expressions profiles of cES cells 'stem' 
state markers during induced neural differentiation 
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Figure 5.5: Changes of gene expressions profiles of cES cells 'pre-
neural' & 'neural' state markers during induced neural differentiation. 
 
ISH of cES cells mRNA of ‘pre-neural’ and ‘neural’ gene expression during the 
first 10 days of cES cells induced neural differentiation show upregulation of 
Sox1 (A-F: compare the bright filed images on Day 0 (B) with that of day 5 
(D)). A number of cES cells express the ‘pre-neural’ state markers Sox3 and 
Otx2 throughout the time course with no apparent changes at different time 
points (G-L and M-R respectively). Bert, the coiled-coiled domain partner of 
ERNI that is implied in Sox2 mRNA regulation during neural induction of the 
chick embryo, is downregulated in the proliferative ‘stem’ state of cES cells (S, 
T) and is upregulated during the first half of the 10-day course (U-V) (Scale 
bar = 100µm). 
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Figure 5.5: Changes of gene expressions profiles of cES cells 'pre-
neural' & 'neural' state markers during induced neural 
differentiation. 
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Figure 5.6: Expression of mesodermal (cBra), endodermal (cSox17) and 
ectodermal (Bert) markers in cES cells during induced neural 
differentiation. 
 
ISH of cES cells during the first 10 days of cES cells induced neural 
differentiation. The mRNA of 3 genes expressed in the embryonic three germ 
layers during early neural induction of the chick embryo is shown. Brachyury 
(Bra), which is a mesodermal marker, is not expressed in cES cells during the 
proliferative ‘stem’ state (A, B) or in the first half of the time course (C, D). The 
N2B27 medium does not lead to exclusive induction of neural tissue as 
Brachyury is upregulated on day 7 (E, F) and continues to be so until the end 
of the time course (G, H). Bert, the coiled-coiled domain partner of ERNI that is 
implied in Sox2 mRNA regulation during neural induction of the chick embryo, 
is expressed exclusively in the embryonic ectoderm during early stages of 
neural induction in the embryo (Papanayotou et. al., 2008). In proliferating cES 
cells Bert is not expressed (I, J). When cES cells are induced to differentiate 
into neurons, Bert is upregulated during the second half of the time course (I-
P). In their proliferative ‘stem’ state, cES cells do not express the endodermal 
transcription factor Sox17, (Q, R). This continues to be the case throughout 
the 10 days time course (S, T & U, V) (Scale bar = 100µm). 
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Figure 5.6: Expression of mesodermal (cBra), endodermal (cSox17) and 
ectodermal (Bert) markers in cES cells during induced neural 
differentiation. 
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5.3.2. Activity of the N2 enhancer and its core subregions 
during induced neural differentiation 
The profile of changes in the activity of different plasmids used in this 
experiment during a 10 day time course induced neural differentiation of 9N2 
cells is presented in Table 14, Table 15, Table 16, Figure 5.7, Figure 5.9, 
Figure 5.10 and Figure 5.11. 
 
5.3.2.1. Assessing transfection efficiency 
 
To assess the efficiency of the transfection procedure, cells were transfected 
with pCAβ, a vector in which GFP expression is driven by a ubiquitously 
expressed promoter (chicken β-actin promoter) intensified by a CMV 
enhancer. The mean transfection efficiency for all experiments was 50.1 ± 
11.4% (not shown in Table 14). In the proliferative state, average transfection 
efficiency was 50.1 ± 10.4 (Table 14, Figure 5.7: A-C). During the time course 
of induced neural differentiation, transfection efficiency varied between days 
with a range of 43.4 – 62.3% (Table 15; Figure 5.9: A1-10, B1-10; Figure 5.10 
and Figure 5.11). By analysis of variance (ANOVA), the variation seen in 
transfection efficiency between days was not statistically significant (Table 15, 
Figure 5.9, Figure 5.10 and Figure 5.11). 
 
5.3.2.2. Chick N2-tk-EGFP 
 
The cN2 enhancer was expressed in 15.5 ± 0.7% of proliferating cES cells 
(Table 14 and Figure 5.7: D-F). After changing the culture conditions to induce 
neural differentiation, cN2 expression changed within the range 0.8–28.9% 
(Table 15 and Figure 5.11: B). The number of cells expressing started to 
increase after day 3, peaked on day 6 then decreased until the end of the time 
course (Figure 5.11: B). These changes were statistically significant (Table 
15). 
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5.3.2.3. Mouse N2-tk-EGFP 
 
The mN2 enhancer was expressed in 13.1 ± 1.2% of proliferating cES cells 
(Table 14 and Figure 5.7: G-I). Similar changes were seen after changing the 
culture conditions to induce neural differentiation as with the chick N2 
enhancer construct (Table 15; Figure 5.9: C1-10; D1-10 and Figure 5.11: C). 
The number of cells expressing mN2 started to increase after day 3 (Figure 
5.9: C4, D4, Figure 5.10 and Figure 5.11: C), peaked on day 6 (Figure 5.9: C6, 
D6; Figure 5.10 and Figure 5.11: C) then decreased until the end of the time 
course (Figure 5.9: C7-10 & D7-10; Figure 5.10 and Figure 5.11: C – compare 
with B). These changes were statistically significant (Table 15: Analysis of 
variance in the activity of the N2 enhancer and subregions in cES cells) but 
there was no significant difference between cN2 and mN2 on days 0, 5 and 10 
(Table 16; Figure 5.9 and Figure 5.10). 
 
5.3.2.4. Mouse N2[176bp]-tk-EGFP 
 
The mouse N2 [176bp] sub-region was expressed by 8.7 ± 4.3% cES cells in 
the proliferating state (Table 14 and Figure 5.7: J-L). The proportion of 
expressing cells varied during the time course from 0.5 – 26.6% (Table 15; 
Figure 5.9: E1-10 & F1-10; Figure 5.10 and Figure 4.2: D). Similar changes 
were seen to those described for the full N2 (Figure 5.9; Figure 5.10 and 
Figure 5.11). Again the changes were statistically significant (Table 15). No 
significant difference was seen between the proportion of cells expressing 
mN2[176bp] and to mN2 [Full length] on days 0, 5 and 10 (Table 16; Figure 
5.9 and Figure 5.10). 
 
5.3.2.5. Mouse N2[73bp]-tk-EGFP 
 
The results were similar to those with the longer core sub-region, with 7.7 ± 
4.2% cells expressing this reporter (Table 14 and Figure 5.7: M-O). Upon 
neural differentiation a range of 1–21.1% cells showed activity (Table 15; 
Figure 5.9: G1-10 & H1-10; Figure 5.10 and Figure 5.11: E), and this changed 
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with a similar time-course to the other reporters described above (Figure 5.9; 
Figure 5.10 and Figure 5.11). There was no significant difference between the 
activities of the two sub- regions of N2 (Table 16 and Figure 5.10). 
 
5.3.2.6.  Mouse [N2 DEL-176bp]-tk-EGFP 
 
A construct containing the N2 region from which the longer (176bp) sub-region 
had been deleted led to few cells expressing the reporter: 0.8 ± 0.2% (Table 
14 and Figure 5.7: Q-S). This did not change during the time course (Table 15; 
Figure 5.9 and Figure 5.10). 
 
5.3.2.7. Mouse [N2 DEL-73bp]-tk-EGFP 
 
Deletion of the smaller sub-region from the mN2 reporter similarly led to few 
expressing cells (0.9 ± 1%; Table 14 and Figure 5.7: T-V) and no significant 
changes during the time course of differentiation (Table 15; Figure 5.9; Figure 
5.10 and Figure 5.11). 
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Figure 5.7: Activity of the N2 enhancer and its subregions in proliferating 
cES cells 
 
A-C: Following transfection of the cES cells with the various tk-EGFP plasmids 
the reporter gene Green fluorescence Protein (GFP) was detected using 
Immunohistochemistry (Positive control pCAB-GFP). Transfection with the full-
length chick sequence of the N2 enhancer coupled to tk-EGFP reporter 
system (Chick-N2-tk-EGFP) resulted in the largest number of GFP positive 
cells (E, F). The use of the mouse sequence of the N2 enhancer in the same 
system (Mouse-N2-tk-EGFP) yielded similar results confirming conserved 
functional elements between the two species. In experiments fragments 
containing different deletions of the N2 mouse enhancer sequence was used 
GFP was detected only when a [176 bp] region (K, L) or a smaller [73 bp] core 
region (N, O), which is contained in former region, were used with the tk-EGFP 
reporter system. Minimal reporter gene protein was detected when these two 
regions were deleted from the N2 full length sequence used in the tk-EGFP 
system [N2 – 176 bp] (Q, R) and [N2 – 73 bp] (T, U) (Scale bar = 80µm) 
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Figure 5.7: Activity of the N2 enhancer and its subregions in proliferating 
cES cells 
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Table 14: Analysis of the activity of the N2 enhancer and its core 
subregions during induced neural differentiation 
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Table 15: Analysis of variance in the activity of the N2 enhancer and 
subregions in cES cells 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Between 
Groups 
1767.111 10 176.711 1.302 0.252 
Within 
Groups 
7463.506 55 135.7   PCAB 
Total 9230.618 65    
Between 
Groups 
4050.107 10 405.011 8.018 >0.001 
Within 
Groups 
2778.366 55 50.516   MN2_FULL 
Total 6828.473 65    
Between 
Groups 
4112.111 10 411.211 7.068 >0.001 
Within 
Groups 
3200.011 55 58.182   MN2_176 
Total 7312.122 65    
Between 
Groups 
2777.772 10 277.777 4.275 >0.001 
Within 
Groups 
3573.355 55 64.97   MN2_73 
Total 6351.127 65    
Between 
Groups 
28.775 10 2.878 1.742 0.094 
Within 
Groups 
90.835 55 1.652   MN2176Del 
Total 119.61 65    
Between 
Groups 
3.449 10 0.345 0.946 0.499 
Within 
Groups 
20.045 55 0.364   MN273Del 
Total 23.494 65    
Between 
Groups 
3608.942 10 360.894 10.18 >0.001 
Within 
Groups 
1949.865 55 35.452   CN2_FULL 
Total 5558.807 65    
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Table 16: Paired analysis of activity of the mouse N2 enhancer and 
subregions in c ES cells. 
 
  Paired Samples Test 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
Day of 
time 
course 
Plasmids 
compared Mean SD 
Std. 
Error 
Mean 
Lower Upper 
t df Sig. (2-tailed) 
Day 0 
Pair 
1 
MN2_FULL - 
CN2_FULL -2.41 8.86 3.61 -11.71 6.88 -0.66 5 0.535 
  
Pair 
2 
MN2_FULL - 
MN2_176 4.37 6.98 2.85 -2.95 11.71 1.53 5 0.185 
  
Pair 
3 
MN2_FULL - 
MN2_73 5.35 10.63 4.34 -5.80 16.51 1.23 5 0.272 
  
Pair 
4 
MN2_FULL - 
MN2176Del 12.28 7.78 3.17 4.11 20.44 3.86 5 0.012* 
  
Pair 
5 
MN2_FULL - 
MN273_Del 12.20 7.77 3.17 4.05 20.36 3.84 5 0.012* 
Day 5 
Pair 
1 
MN2_FULL - 
CHKN2FUL -2.188 4.83 1.97 -7.25 2.88 -1.10 5 0.318 
  
Pair 
2 
MN2_FULL - 
MN2_176 3.77 8.09 3.30 -4.72 12.26 1.14 5 0.306 
  
Pair 
3 
MN2_FULL - 
MN2_73 4.99 14.28 5.83 -9.99 19.98 0.85 5 0.431 
  
Pair 
4 
MN2_FULL - 
MN2NO176 20.48 6.48 2.64 13.68 27.27 7.74 5 0.001* 
  
Pair 
5 
MN2_FULL - 
MN2NO73 23.13 6.79 2.77 16.00 30.26 8.34 5 
<0.001
* 
Day 10 
Pair 
1 
MN2_FULL - 
CHKN2FUL -0.43 0.81 0.33 -1.29 0.41 -1.31 5 0.245 
  
Pair 
2 
MN2_FULL - 
MN2_176 -0.08 0.41 0.16 -0.51 0.34 -0.50 5 0.637 
  
Pair 
3 
MN2_FULL - 
MN2_73 -0.63 1.11 0.45 -1.80 0.54 -1.38 5 0.225 
  
Pair 
4 
MN2_FULL - 
MN2NO176 0.18 0.44 0.18 -0.28 0.64 1.00 5 0.36 
  
Pair 
5 
MN2_FULL - 
MN2NO73 0.07 0.62 0.25 -0.58 0.73 0.29 5 0.779 
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Figure 5.8: Activity of the N2 enhancer and its subregions during 
induced differentiation of cES cells 
 
The activity of the N2 enhancer and its sub-regions in cES cells during the first 
ten days of a 21-day monolayer culture in N2B27 defined medium induced 
neuronal differentiation protocol. GFP was detected throughout the time 
course with the positive control pCAB-GFP indicating independence of the 
transfection efficiency from the time point (A1-A10 and B1-B10). The 
percentage of green cells detected following the transfection of the full-length 
mouse sequence of the N2 enhancer increased between day 4 and day 7 of 
the time course (C4, D4 and C7, D7 respectively).  Similar changes were 
noted when the 176 bp and 73 bp core regions were used (E1-10, F1-10 and 
G1-10, H1-10 respectively). Throughout the time course, the activity of the N2 
enhancer is negligible when these 176 bp and 73 bp subregions are deleted 
(I1-10, J1-10 and K1-10, L1-10 respectively) indicating the specificity of this 
activity to the 176 bp and 73 bp core regions of the N2 enhancer (Scale bar = 
50µm). 
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Figure 5.9: Activity of the N2 enhancer and its subregions during 
induced differentiation of cES cells 
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Figure 5.10: Quantification of activity of the N2 enhancer and its 
subregions during induced differentiation of cES cells. 
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Figure 5.11: Patterns of activity of the N2 enhancer and its subregions 
during a 10 days time course of induced neural differentiation of cES 
cells 
 
The mean percentages of green cells detected following the transfection of the 
N2 enhancer and its sub-deletions’ tk-EGFP plasmids are plotted against time 
points of first 10 days of monolayer culture N2B27 induced neural 
differentiation protocol to compare patterns of activity of the N2 enhancer and 
its regulatory subregions under condition that induce neural differentiation. A: 
The positive control plasmid pCAB-GFP’s enhancer activity changed during 
the time course ranging between 40% and 60% approximately. B: The activity 
of the chick N2 full length enhancer has a distinctive sigmoid pattern that 
shows its unchanged activity in the first third of the time course, increase 
activity in the second third of the time course and a late decrease in its activity 
in the last third. The activity of the mouse N2 enhancer (C) and its core 176 bp 
(D) and 73 bp (E) sub-regions have patterns which resemble the sigmoid 
pattern of the chick N2 full length enhancer (in shape and mean percentage 
changes) under these conditions. The activity of the N2 enhancer is reduced 
significantly when the 176 bp and 73 bp subregions are deleted (F and G 
respectively). This minimal activity has no resemblance in its pattern to neither 
that of the chick N2 full length or the mouse N2 full-length patterns. 
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Figure 5.11: Patterns of activity of the N2 enhancer and its subregions 
during a 10 days time course of induced neural differentiation of cES 
cells 
 
 
Of % 
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5.3.3. Sox2 mRNA expression correlates N2 activity 
during induced neural differentiation 
No significant fluctuation in transfection efficiency was observed during the 
time course (Figure 5.12: A0-A10 and B0-B10) also see Table 15. On the 
other hand, both the proportion of cells activating the N2 enhancer (Figure 
5.12: C0-C10; D0-D10 and Figure 5.13) and the expression of Sox2 mRNA 
(Figure 5.12: E0-E10 & F0-F10 and Figure 5.13) varied between days. In the 
first 3 days of the time course Sox2 mRNA is downregulated (Figure 5.12: E0, 
E3 & F0, F3). During the same period the proportion of cells expressing N2 
does not seem to change (Figure 5.12: C0, C3). On day 4 Sox2 mRNA starts 
to increase (Figure 5.12: E4, F4 and Figure 5.13). This is accompanied by 
increased activity of the N2 enhancer (Figure 5.12: C4, D4 and Figure 5.13).  
 
In the second half of the time course, both Sox2 expression and the number of 
cells activating the N2 enhancer first increase, and then decrease (Figure 
5.12: C5-C10; D5-D10; E5-E10; F5-F10 and Figure 5.13). N2-enhancer 
expression peaks on the 6th day (Figure 5.12: C6, D6 and Figure 5.13), one 
day earlier than the peak expression of Sox2 mRNA (Figure 5.12: E7, F7 and 
Figure 5.13).   
 
A correlation calculation between Sox2 mRNA expression and the activity of 
the mN2 enhancer of Sox2 was conducted to investigate any association 
between the two during the time course. The test was done on days 0 – 10 of 
the time course with N=11 data pairs. The null hypothesis (no association) was 
rejected at (p<0.05).  
 
Pearson’s r was 0.665. With 9 degrees of freedom (N-2) and alpha level of 
0.05 the null hypothesis was rejected. The critical value of r for these two 
parameters was 0.521. We conclude that there is a significant positive 
correlation between the activity of N2 and the mRNA expression of Sox2 in 
cESCs induced to neural differentiate in vitro. 
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Figure 5.12: Comparison between dynamic changes in Sox2 mRNA 
expression and the activity of the N2 enhancer during induced neural 
differentiation of cES cells 
 
A 10 days time course of cES cells induced neural differentiation was used to 
compare the activity of the N2 enhancer (top four panels) to that of the mRNA 
expression of Sox2 (bottom two panels). First, the activity of the positive 
control plasmid pCAB-GFP is shown in the top panel confirming good 
transfection efficiency on all points of the time course (A01-10 and B0-10). The 
activity of the N2 enhancer in cES cells increased in the 1st half of a 10-days 
time course of induced neural differentiation (D0-D6) and decreased in the 2nd 
half (D6-D10). This variability was not related to transfection efficiency 
assessed by the positive control plasmid shown in the top panel. By ISH The 
number of cells expressing Sox2 mRNA in cESCs during a parallel time 
course under similar condition was noted to change with initial decrease in the 
1st third of a 10-days time course (F0-F3); then an increase in the 2nd third 
peaking at day 7 (F4-F7); then another decrease in the last third (F8-F10). 
These changes in the N2 activity and Sox2 mRNA expression were quantified 
and found to be significantly correlated (See text)(Scale bar = 50µm) 
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Figure 5.12: Comparison between dynamic changes in Sox2 mRNA 
expression and the activity of the N2 enhancer during induced neural 
differentiation of cES cells 
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Figure 5.13: Dynamic changes in Sox2 mRNA expression correlates with 
the activity of the N2 enhancer during induced neural differentiation of 
cES cells 
 
This chart shows the correlation between Sox2 mRNA expression and N2 
activity during a 10 days time course. By comparing the percentage of cells 
expressing Sox2 mRNA (blue) and those with active N2enhancer (red) from 2 
independent experiments we find that expression of Sox2 mRNA is 
significantly correlated with the activity of N2 enhancer (r = 0.665) p < 0.05 
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Figure 5.13: Dynamic changes in Sox2 mRNA expression correlates with 
the activity of the N2 enhancer during induced neural differentiation of 
cES cells 
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5.4. Discussion 
 
5.4.1. Time course of changes in gene expression 
during induced neural differentiation of cES cells 
A time course of the changes in the expression of 10 markers was undertaken 
for cES cells in the proliferating state (t=0) and on each day thereafter 
following removal of conditions that support proliferation and which induce 
differentiation. In this case N2B27 medium was used in the presence of 1% 
fetal calf serum but without the addition of retinoic acid as described 
elsewhere in this thesis.  
 
In general, it was found that proliferating ES cells express the proliferating 
‘stem’ state markers Sox2, Nanog, ERNI and Oct4. The expression of early 
neural markers (including Sox2, Sox3 and Otx2) starts to increase in the 
second half of the time course. The marker of the most mature neural plate 
used in this set was Sox1, which starts to be expressed on day 5. At the same 
time some cells acquire expression of the mesendodermal marker Brachyury 
(Kispert et al., 1995) from day 6, but no expression of the early endodermal 
marker (Kimura et al., 2006) was observed at any stage during the time 
course. Thus, N2B27 under these conditions induces differentiation into neural 
cells; at least a proportion of cells also differentiate into mesoderm or 
mesendoderm, judged by the expression of Brachyury. 
 
5.4.2. Activity of the N2 enhancer and its sub-regions in cES 
cells  
In chick embryonic stem cells, N2 was found to be the Sox2 enhancer with 
highest activity in the proliferative state (Chapter 3). N2 is also the first 
enhancer to be activated in the embryo after gastrulation, when Sox2 
expression begins in the forming neural plate (Collignon et al., 1996; Rex et 
al., 1997b; Uchikawa et al., 2003; Uwanogho et al., 1995). 
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When cES cells were induced to differentiate in vitro, N2 activity increased, as 
did expression of Sox2 mRNA.  As in the embryo where Sox2 expression is 
downregulated between pre-gastrulation stages and the end of gastrulation 
(stages 4-5) when it reappears in the neural plate, there appears to be 
downregulation of Sox2 with no loss of activity of the N2 enhancer.  
 
This could be partially due to timing of transfection and accumulation of the 
GFP protein. As N2 is active in proliferating cES cells, transfection of the 
plasmid in the proliferating phase at the beginning of the time course could 
transiently lead to GFP resultant from such activity. Similarly, as fluorescent 
cells are assayed 36-48 hours following transfection, it is possible that some of 
the GFP detected would be resulting from this second increase in activity of 
the N2 enhancer. ISH detects mRNA present at the time of fixing and provide 
a snapshot of the state of gene expression during such time. On contrast, the 
activity of the enhancer is accumulative and provides information on several 
time points.  
 
The increase in the N2 activity, which seems to accompany the upregulation of 
Sox2 in the second half of the time course between the proliferating stage and 
the acquisition of neural fate, occurs about 5 days into the time-course of 
induced differentiation. These findings suggest that N2 contains the 
information to direct expression of Sox2 both in embryonic stem cells in the 
proliferating state and during neural differentiation, as well as in the early 
neural plate of the embryo. 
 
Following on from the original paper describing the various enhancers of Sox2 
(Uchikawa et al., 2003), Kondoh’s laboratory identified two highly conserved 
sub-regions of the N2 enhancer (Iwafuchi et al., 2008). Both the full N2 
enhancer (550 bp) and its two sub-regions were found to be conserved 
between mouse and chick in vivo. In the latter study, the full mouse N2 and its 
two sub-regions (named N2-176 and N2-73) were found to direct expression 
of a reporter in the Sox2 expression domain at stage 4+ when coupled with a 
minimal promoter and electroporated into primitive streak stage chick embryos 
 158 
(Iwafuchi et al., 2008). Furthermore, the full length of mouse N2 sequence, as 
reported in the chick in chapter 3, is active in mouse embryonic stem cells in 
their proliferating state (Catena et al., 2004). The core sub-regions of the N2 
enhancer had similar activity to the full length N2 (Catena et al., 2004). 
 
Sox2 is expressed in the Inner Cell Mass of early mouse embryos (Avilion et 
al., 2003) as well as in developing neural tissue (Zappone et al., 2000). This 
expression appears to be driven by a non-coding region 5’ of the Sox2 locus 
which can direct expression to the inner cell mass as well as later to the 
anterior neural plate (Zappone et al., 2000). This non-coding region is located 
between 3.3 and 5.7 kb upstream of the Sox2 coding sequence. A sequence 
homologous to the chick N2 enhancer is found between 3.8 and 4.3 kb 
upstream of the Sox2 reading frame and therefore is entirely contained within 
the 5’ region identified by Zappone et al. (2000) (Uchikawa et al., 2003). In 
vitro, this 5’ region of Sox2 was active in neural progenitor cells derived from 
anterior neural tube but not from the spinal cord (Zappone et al., 2000). This 
very regulatory element was reported later by the same group to drive 
expression of Sox2 to mouse ES cells (Catena et al., 2004). Similar findings 
were also reported for mouse ES cells by Kondoh’s group using the 550 bp N2 
enhancer and its sub-regions (Iwafuchi et al., 2008). 
 
Catena et al (2004) further analysed the 5’ regulatory sequence and identified 
a core sub-region with two POU binding sites that can recapitulate the activity 
of the entire original 5’ region. Mutation of these POU sites rendered this core 
region inactive for both ‘neural progenitors’ and ‘multipotent’ states of ES cells 
(Catena et al., 2004). Further analysis by Chromatin Immunoprecipitation 
reported different members of the POU family of transcription factors are 
associated with this region in the two states. In the ‘stem’ state PouV is bound 
to these sites, whereas in the ‘neural’ state these sites are occupied by Brn1 
and Brn2 (Catena et al., 2004). Both Brn1 and Brn2 (also known as Qin in the 
chick embryo) are expressed in the early anterior neural plate of late primitive 
streak and neurulating stage embryos (Witta et al., 1995) . 
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In the chick, Kondoh’s group also analyzed the activity of the N2 enhancer and 
identified two sub-regions: the first is 176bp and the second is a 73 bp core 
region is contained within the former (Iwafuchi et al., 2008) (see Appendix 1). 
The two POU sites described by Catena et al. (2004) are contained within the 
smaller 73bp sub-region. Kondoh’s group also confirmed the finding of Catena 
et al (albeit using Electrophoretic Mobility Shift Analysis rather than Chromatin 
Immunoprecipitation) that PouV is associated with the 73bp core region in 
mouse ES cells in the proliferating state (Iwafuchi et al., 2008). However for 
the neural plate they found that the activity of the core region depends on 
binding of a different transcription factor to the 73 bp sequence: Otx2. All of 
these studies indicate that the activity of Sox2 in cultured mouse embryonic 
cells in the ‘stem’ and ‘neural’ states, as well as in Sox2 expressing mouse 
ICM cells and later in the early forebrain domain all rely on the 73 bp N2 core 
region. 
 
The results reported in this chapter support the findings from the mouse: the 
enhancer N2 has the highest activity in proliferating chick ES cells. They also 
confirm that the smaller 176 and 73 bp core regions are sufficient to direct 
expression of a reporter. Furthermore, and for the first time, this chapter 
reports that blastoderm-derived cES cells induced to differentiate in vitro 
display an increase in activity of the N2 enhancer (and both its sub-regions), 
correlated with the increase in the number of cells expressing Sox2 mRNA. 
This suggests that the 73bp core region of the N2 enhancer contains sufficient 
information to direct expression of Sox2 in both the ‘stem’ state and during 
induced neural differentiation state as well as in the anterior neural plate of the 
embryo.  
 
Analysis of the N2 enhancer identified 66 conserved potential transcription 
factor binding sites, which can be reduced to 35 highly matching sites (see 
Appendix). Within the shorter sub-regions of 176bp and 73 bp the list drops to 
18 and 7 sites, respectively. Mutational analysis on these regions is required 
to determine which of these are required for the activity of these core 
enhancer regions in vivo and in vitro. A similar approach has been used to 
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show that factors associated with Wnt and FGF signalling synergistically 
activate the N1 (posterior neural plate) enhancer (Takemoto et al., 2006).  
 
A recent functional study in the chick identified another mechanism regulating 
Sox2 expression in the early neural plate (Papanayotou et al., 2008). In this 
study, interactions between three coiled-coil domain proteins (ERNI, Geminin, 
and BERT), the heterochromatin proteins HP1α and HP1γ (transcriptional 
repressors) and the chromatin-remodelling enzyme Brm (as activator) control 
the timing of activation of the N2 enhancer. Chick ES cells provide a platform 
where factors identified in the embryo could be tested to explore whether the 
same factors will be interpreted in the same way by the ES cells. 
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General Discussion 
 
The Sox2 gene has been implicated as a key factor in several important 
developmental processes (Miyagi et al., 2009; Zhao et al., 2004). In the 
developing embryo, Sox2 is first expressed in a broad domain of the pre-
primitive-streak stage embryo in both mouse (Avilion et al., 2003; Wood and 
Episkopou, 1999; Zhappone et al., 2000) and chick (Bertocchini, Boast and 
Stern, in preparation). Then, expression is downregulated before reappearing 
in the developing neural plate soon after the end of gastrulation (Kondoh et al., 
2004; Papanayotou et al., 2008; Rex et al., 1997b; Uchikawa et al., 2003;  
Uwanogho et al., 1995). Thereafter it remains expressed almost throughout 
the central nervous system and eventually ending in the residual neural 
progenitors of adult ventricular zone as well as in a number of domains outside 
the CNS, including sensory placodes and other sites (bu-Elmagd et al., 2001; 
Ishii et al., 1998; Le et al., 2002; Rex et al., 1994; Rex et al., 1997b; 
Uwanogho et al., 1995). The pioneering work of Hisato Kondoh’s group 
demonstrated that at different sites, Sox2 expression is controlled by distinct 
enhancers. They identified 10 different enhancers within 25 highly conserved 
sequences, situated both upstream and downstream of the single coding exon 
of Sox2 (Kondoh et al., 2004; Uchikawa et al., 2003).  
 
In the neural plate, Sox2 expression begins in the most anterior domain, 
encompassing the forebrain, midbrain and anterior hindbrain to the level of the 
otic vesicle (Papanayotou et al., 2008; Rex et al., 1994; Rex et al., 1997b; 
Uwanogho et al., 1995). This expression is regulated by the N2 enhancer, 
located upstream of the Sox2 coding region in chick, mouse and human 
(Uchikawa et al., 2003). The remainder of the CNS (posterior hindbrain and 
spinal cord) derives from a much smaller region, two small triangles of epiblast 
on either side of Hensen’s node that have been termed the “stem zone” 
(Delfino-Machin et al., 2005). A different enhancer, N1, drives Sox2 
expression in this domain (Uchikawa et al., 2003). 
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Sox2 is also expressed in mouse (Maruyama et al., 2005; Masui et al., 2007) 
and human (Card et al., 2008; Fong et al., 2008) embryonic stem cells and it is 
usually considered one of the genes whose expression defines pluripotency 
and/or the capacity for self-renewal (Rizzino, 2009; Wang et al., 2007). 
Consistent with this, Sox2 is also expressed in the cells of the inner cell mass 
of early mouse embryos, from which mouse ES cells are derived. In contrast, 
original reports on Sox2 expression in chick embryos did not find expression 
prior to the late primitive streak stage (Rex et al., 1997b; Uwanogho et al., 
1995). A recent re-examination of this issue did reveal a very early, transient 
phase of Sox2 expression in the chick embryo before gastrulation, at stage 
XIII (Eyal-Giladi and Kochav, 1976) as well as its expression in chick 
embryonic stem cells, derived from pre-primitive-streak stage embryos (F. 
Bertocchini, S. Boast and C.D. Stern, in preparation). These findings suggest 
that the avian and mammalian systems may not differ in their expression of 
SoxB1 class genes as much as was previously thought. 
 
ES cells isolated from the chick embryo share many ES cell features identified 
in their mammalian counterparts including the capacity for self-renewal and 
their ability to contribute to all somatic cell types (Lavial and Pain, 2010; Pain 
et al., 1996; Pain et al., 1999) and the expression of markers of pluripotency 
and/or self-renewal, such as PouV (the chick homologue of Oct3/4) and 
cNanog (Lavial et al., 2007) in addition to Sox2. However unlike their mouse 
counterparts, chick embryonic stem cells derived from the early blastdoderm 
appear to be unable to contribute to the germ line (Lavial and Pain, 2010; Pain 
et al., 1999). This is not a property of avian cells in general because it is 
possible to derive self-renewing cell lines from primordial germ cells that do 
have the ability to contribute to both somatic and germ lines (McGrew et al., 
2004; Naito et al., 1994; Petitte et al., 1990). These primordial-germ-cell-
derived (PG) cell lines also express markers of self-renewal and pluripotency 
including PouV, Nanog and Sox2 in addition to the germ cell markers Vasa 
and Dazl (Lavial et al., 2009; Montono et al., 2008; Tsunekawa et al., 2000 
and S. Intarapat and Stern, unpublished observations). These observations 
suggest that the so-called chick embryonic stem cells are not strictly 
equivalent to mouse ES cells (which can contribute to both somatic and germ 
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lineages), but rather resemble the stem cell lines that can be derived from the 
epiblast of slightly later mouse embryos, known as Epiblast Stem cells whose 
potential is restricted to somatic descendants (Brons et al., 2007). 
 
Hisato Kondoh’s laboratory identified enhancers directing Sox2 expression in 
embryonic tissues, but since chick ES cells were not known to express this 
gene, the enhancers responsible had not been sought. This was one of the 
aims of this project. The starting point is the hypothesis that the expression of 
Sox2 in these cells is governed by mechanisms that are conserved between 
species. A recent study identified a region of non-coding DNA that is sufficient 
to drive Sox2 expression mouse ES cells (Catena et al., 2004; Zappone et al., 
2000). Cross-species comparisons and genome alignments reveal that this 
region contains within it the putative mouse homologue of the chick N2 
enhancer identified by Uchikawa et al. (2003). For this reason, this work 
started by exploring whether the chick N2 enhancer has similar properties in 
chick ES cells, using constructs containing a minimal Tk promoter downstream 
of the enhancer region to be tested, driving expression of GFP as a 
fluorescent reporter. Constructs containing each of the Sox2 conserved non-
coding blocks were kindly provided by Professor Hisato Kondoh. These were 
transfected into three different established lines of chick ES cells. 
 
Following transfection of these 26 different constructs only that containing N2 
was found to have significant activity in proliferating chick ES cells. The 
enhancer N2 is contained within the region upstream of Sox2 which was found 
to be active in mouse ES cells (Catena et al., 2004) and which can also drive 
expression in mouse neural progenitors (Zappone et al., 2000) and, in the 
chick, in a wide anterior domain of the neural plate destined to form the future 
brain (Uchikawa et al., 2003). The N2 enhancer was further dissected into 
sub-regions, which were studied for their activity in chick ES cells. In 
agreement with findings from the Kondoh laboratory using mouse ES cells, an 
inner “core” region of 73 bp contained within a larger 176 bp domain, are both 
sufficient and necessary for expression in chick ES cells. These regions 
contain several locations corresponding to putative POU binding sequences 
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(Catena et al., 2004; Iwafuchi et al., 2008; Uchikawa et al., 2003) (also see 
Appendix 1).  
 
Since the N2 enhancer appears to be responsible for directing expression of 
Sox2 in both proliferating ES cells and in the forming anterior neural plate, 
what are the dynamics of the changes in its activity during the process of 
differentiation in vivo and in vitro? In vivo, the early expression phase appears 
to occur at stage XIII of Eyal-Giladi & Kochav (1976) (Bertocchini, Boast & 
Stern, in preparation) and the late phase starts at Hamburger & Hamilton 
(1951) stage 4+, with no express in the intervening period. (Kondoh et al., 
2004; Papanayotou et al., 2008; Rex et al.,1997b; Uchikawa et al., 2003; 
Uwanogho et al., 1995). To examine the dynamics of Sox2 expression and the 
activity of the enhancers directing this during induced neural differentiation of 
chick ES cells, it was necessary first to design a reproducible protocol for 
obtaining neural differentiation of chick ES cells in vitro. Several methods have 
been reported for mouse ES cells (Bain et al., 1995; Dani et al., 1997; Ying 
and Smith, 2003) but these have not systematically be tested in the chick. 
 
The next part of the project therefore moved on to compare two methods for 
inducing chick ES cells to acquire a neural fate. One was an Embryoid Body 
(EB) -based protocol (based on Bain et al., 1995) and the other a monolayer 
culture in defined medium containing differentiation-inducing factors (based on 
Ying et al., 2003; Ying and Smith, 2003). In both cases cES cells differentiated 
into neuron-like cells which express the neurofilament-associated antigen 
3A10 (Furley et al., 1990; Storey et al., 1992;Yamada et al., 1991) and the 
neuronal class 3 β-tubulin antigen TUJ-I (Ferreira and Caceres, 1992; Maurer 
et al., 2007; Miura and Kameda, 2001; Scott et al., 1990). However the 
monolayer culture method was found to be more reliable and more effective. 
 
Next, the gene expression profile of 10 genes that mark different cell types 
and stages of neural plate development in the embryo was assayed by in situ 
hybridisation in proliferating ES cells and over a 10-day time-course during 
induced neural differentiation. We found that proliferating cES cells have a 
gene expression profile which is similar to that of proliferating mouse and 
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human ES cells (Adewumi et al., 2007; Smith, 2001). Marked upregulation of 
the expression of SoxB1 genes Sox2 and Sox1 was found to occur in the 
second half of the time course. 
 
We hypothesize that this upregulation of Sox2 in the second half of the 
induced neural differentiation time course is comparable with the second 
phase of Sox2 expression in the embryo, when the neural plate starts to 
become distinct at stage 4+-5 (Kondoh et al., 2004; Papanayotou et al., 2008; 
Rex et al.,1997b; Uchikawa et al., 2003; Uwanogho et al., 1995). When the 
activity of the N2 enhancer was examined during the 10-day time-course, a 
marked increase in the activity of the N2 enhancer was found to correlate with 
the upregulation of Sox2 mRNA expression observed in the second half of the 
time course. Taken together, these findings indicate that the N2 enhancer is 
conserved in the chick and mouse not only in the DNA sequence, but also in 
its regulatory functions in both cultured ES cells and in the embryo.  
 
The sequence of the N2 enhancer and its essential core regions is highly 
conserved between mammals and chicken (Kondoh et al., 2004;Uchikawa et 
al., 2003) and (Appendix 1). In the core sequence of 73 bp, two POU binding 
sites are conserved. These sites are both necessary and sufficient for 
expression in mouse ES cells in both the proliferating and induced neural 
states (Catena et al., 2004 and this thesis). These POU sites have been 
reported to be bound by Oct3/4 in ES cells in the proliferating state (Catena et 
al., 2004; Nichols et al., 1998; Rosner et al., 1990; Tanaka et al., 2004), 
whereas the related POU factors Brn1 and Brn2 may bind to the same sites in 
differentiating neural cells (Catena et al., 2004; Eisen et al., 1995; Josephson 
et al., 1998; Matsuo-Takasaki et al., 1999; Witta et al., 1995).  In the early 
chick neural plate the activity of this core region was similarly attributed to 
POU factors as well to Otx2 (Iwafuchi et al., 2008). These findings suggest 
that the essential regions (73 bp core of a larger 176bp essential region) of the 
N2 enhancer of Sox2 contain the instructions required for expression in cES 
cells in the growing phase and during neural differentiation, as well as in 
embryos before gastrulation and at the early neural plate stage.  
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In conclusion, this study revealed that the machinery controlling Sox2 
expression in chick ES cells in their undifferentiated, self-renewing state are 
comparable to those controlling it pre-gastrulating embryos as well as in the 
later phase of early neural plate formation in vivo and during induced neural 
differentiation of ES cells. A single enhancer region, N2 (and specifically the 
73 bp core of an important sub-region of 176 bp) is necessary and sufficient to 
account for expression in all four of these situations. This is to some extent a 
surprising finding especially because 9 other enhancers have been identified 
that contribute to controlling Sox2 expression in vivo in a number of different 
sites, including 4 enhancers in addition to N2 which direct expression to the 
central nervous system (Kondoh et al., 2004; Uchikawa et al., 2003)  It seems 
that for these earliest stages of development and during ES cell growth and 
differentiation, the main mechanism regulating the changes in the expression 
of this gene relies on differential expression of the transcription factors that 
bind to this single enhancer, which appear to be different members of the POU 
family. 
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Figure 30: Thesis Diagram 
 
 
 
 
A single enhancer region, N2 (and specifically the 73 bp core of an important 
sub-region of 176 bp) is necessary and sufficient to account for expression of 
Sox2 in chick ES cells cultured in vitro iunder conditions that maintains their 
undifferentiated, self-renewing state as well during their induced neural 
differentiation. This function of the N2 enhancer core region is comparable to 
that controlling Sox2 expression in vivo during the early phase of neural plate 
formation. This thesis suggests that for embryonic development and during ES 
cell growth and differentiation, the main mechanism regulating the changes in 
the expression of Sox2 relies on differential expression of the transcription 
factors that bind to this single enhancer, which appear to be different members 
of the POU family 
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APPENDIX I 
 
1] Inter-species comparison of the N2 enhancer sequence 
 
>N2 Chick 
GAGGAAATTTCTCTGTACGTTTTCGTCTTCGGCTTTTTTTTTTTTA 
ACGTAATGAAATTAAAACTTTTGGAGCTCAGAGTTGACATTTTGCGGAAA 
ATTGAGTTATCAAGGCAGTAATTATTTCACAGGGAGATAAAACTCTCATA 
GCCCTAACTGTCAAATAGGGCCCTTTTCAGATTTTAATTACAAAATAAAA 
TTAGTCTGCTCTTCCTCGGAAGGGTTTGTGAGTGGCTAAACAGAGCTTTC 
CCCAATACTGGTGGTCGTCAAACTCTGCTAATTAGCAATGCTGAGAAAT 
TCCAGTTAACAAGGACATTCTCTAAGTCTCTGCAGGTTCCCTGCCGTTCG 
CCTTCATTTCCATAAGAAGATTAAGAGTGGAGGGGAACACACTCAAATGC 
AGATGCAGAAAAGAAGCGTTTTTAACAAGCATCATAATAGTAAGATGCT 
TGGCTAGTTCTCACCTAATTAACTGCAAGTTAAACCTCTATTTGCAGCTAA 
GGACAAAAAATGGAGCTGCAATCTTCCATCTCCACAAGAC 
 
>N2 Mouse 
TAGAAAGCCTTTCTGTACATTTTCTCTTATTTTTCTTGCTACTTTTCCTT 
ATGTAATGAAATTAAAACTTTTGGA ACCCACAGTTGACATTTTTCAGAAA 
ATTGAGTTATCAAGGCAGTAATTATTTCTCGGGGAGATAAAACTCTCATA 
GCCCTAACTGTCAAATAGGGCCCTTTTCAGATTTTAATTACAAAATAAAA 
TTAGTCTGCTCTTCCTCGGAATGGTTGGCGAGTGGTTAAACAGAGCTTTC 
CCCCAATACTGGTGGTCGTCAAACTCTGCTAATTAGCAATGCTGAGAAAT 
TCCAGTTAACAAGGGCATTCTCCGAGACTCTGCAGGTCCCCTGCCGTTC
GCCTTCATTTCCATAAGGAGATTAGGAGAGGAGGGGAACCCACTCAAAT
GCAGATGCAGGAGCGAAGCGTTTTTAACAAGCATCATAATAGTAAGATGC
TTGGCTAGTTCTCGCTAATTAACTGCAACTTAAACCTCTATTTGCAGCTAA 
GAAGAAAAAAATAAGTCTACAGTCCGCACCTCCACAACAT 
 
>N2 Human 
TAGAAAACCTTTCTGTACATTTTCTTCTATTTTTCT CACTTTTTCCTT 
ACATAATGAAATTAAAACTTTTGGAGCCTACAGTTGACATTTTTCAGAAA 
ATTGAGTTATCAAGGCAGTAATTATTTCACGGGGAGATAAAACTCTCATA 
GCCCTAACTGTCAAATAGGGCCCTTTTCAGATTTTAATTACAAAATAAAA 
TTAGTCTGCTCTTCCTCAGAATGGTTTGTGAGTGGTTAAACAGAGCTTTC 
CCCCAATACTGGTGGTCGTCAAACTCTGCTAATTAGCAATGCTGAGAAAT 
TCCAGTTAACAAGGACATTCTCCAAGACTCTGCAGGTTCCCTGCCGTTCG 
CCTTCATTTCCATAAGAAGATTAAGAGAGGAGGGGAACACACTCAAATGC 
AGATGCAGAAAAGAAGCGTTTTTTAACAAGCATCATAATAGTAAGATGCT 
TGGCTAGTTCTCACCTAATTAACTGCAAGTTAAACCTCTATTTGCAGCTAA 
GAAGAAAAAATAAGTCTACAGTCCCCTGTCTCCACAAAAT 
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2] Analysis of sequence homology 
 
Out of 530 bases of its full length in chick there are 477 and 490 base matches 
in their mouse and human counterparts rendering 90% and 93% sequence 
homology with these two species respectively. By By utilizing Mulan software 
(Loots and Ovcharenko, 2007) 66 multi-conserved transcription factor-binding 
sites (TFBS) were identified (Data not shown). The number of TFBS could be 
reduced to 35 when the search setting was increased to “High specificity” 
(Table Appx. 1 and Figure Appx. 1 &2). 
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Table Appx. 1: Conserved “highly specific” Transcription Factor Binding 
Sites (TFBS) identified in the sequence of Sox2 N2 enhancer using Mulan 
software (Loots and Ovcharenko, 2007) . 
 
No. 
Transcription 
Factor Name 
Location in 
the N2 
sequence Sequence 
1 PAX 113-123 agTAATTATTt 
2 VMYB 149-157 cctAACTGt 
3 SRF 153-171 actgTCAAATAGGGccctt 
4 SRF 155-168 tgTCAAATAGGGcc 
5 SRF 156-173 gTCAAATAGGGccctttt 
6 SRF 157-171 TCAAATAGGGccctt 
7 PLZF 166-194 GCCCTTTTCAGATTTTAATTA 
8 PF1 176-190 gatttTAATTacaaa 
9 CEBP 183-194 aTTACAAAAtaa 
10 CEBP 183-194 aTTACaaaataa 
11 EVI1 186-194 ACAAAATAA 
12 NFY 224-234 gtgAGTGGcta 
13 NFY 225-237 tgAGTGGctaaac 
14 GLI 255-262 tgGTGGtc 
15 ATF 256-267 ggtggTCGTCAa 
16 PAX3 261-273 TCGTCAAACtctg 
17 CREB 262-267 CGTCAa 
18 OCTI 268-279 acTCTGCTAATT 
19 CHX10 270-283 tctGCTAATTAgca 
20 CHX10 272-285 tgcTAATTAGCaat 
21 NFKB 285-300 tgctgAGAAATTCCAg 
22 AP1 285-297 tgcTGAGAAAttc 
23 NFKAPPAB 290-299 AGAAATTCCa 
24 ROSA1 301-313 ttaacaAGGACAt 
25 OCT 348-360 tTCATTTCCATaa 
26 OCTI 349-359 tcATTTCCATa 
27 OCT 349-359 tcaTTTCCATa 
28 VMAF 390-408 aaatGCAGATGCAGAaaag 
29 WHN 408-418 gaaGCGTtttt 
30 NFY 439-452 gaTGCTTGGCTagt 
31 CAAT 441-452 tgCTTGGctagt 
32 NFY 441-453 tgCTTGGctagtt 
33 CHX10 455-468 tcaCCTAATTAact 
34 CHX10 457-470 accTAATTAACtgc 
35 AFP1 462-472 ATTAACTGCAA 
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Figure Appx. 1: Bioinformatics analysis of the N2 enhancer and 
identification of conserved Transcription Factors Binding Sites (TFBS). 
 
Sequence homology of the N2 enhancer in the chick, mouse and man with the 
176 bp and 73 bp core regions having the highest interspecies homology 
(100% for 73 bp between chick and man). The N2 enhancer encodes 66 
conserved transcription factor-binding sites with 35 being with high specificity. 
 
 
 
 
 
 
 
 
 
 202 
Figure Appx. 2: Sequence analysis of the N2 enhancer and localization of 
conserved Transcription Factors Binding Sites (TFBS). 
 
This figures shows a summary of the N2 enhancer sequence analysis in the 
mouse and chick with location of the 176 bp and 73 bp core regions as well as 
the main TFBS location within its sequence. A total of 3 POU binding sites are 
present in the 176 bp sub region out of which two are embedded in the 73 bp 
core region. 
 
 
